Cell Cycle

Introduction

A cell cycle is a series of events that take place in a cell as it grows and divides. A cell spends most of its time in what is called interphase, and during this time it grows, replicates its chromosomes, and prepares for cell division. The cell then leaves interphase, undergoes mitosis, and completes its division. The resulting cells, known as daughter cells, each enter their own interphase and begin a new round of the cell cycle.

Gentaur Cell Cycle is the ordered sequence of events that occur in a cell in preparation for cell division. The cell cycle is a four-stage process in which the cell increases in size (gap 1, or G1, stage), copies its DNA (synthesis, or S, stage), prepares to divide (gap 2, or G2, stage), and divides (mitosis, or M stage). The G1, S, and G2 stages from interphase represent the time between cell divisions. Based on the stimulating and inhibitory messages a cell receives, it “decides” whether to enter the cell cycle and divide.

Proteins that play a role in stimulating cell division can be classified into four groups: growth factors, growth factor receptors, signal transducers, and nuclear regulatory proteins (transcription factors). For a stimulating signal to reach the nucleus and “activate” cell division, four main steps must occur. First, a growth factor must bind to its receptor on the cell membrane. Second, the receptor must be temporarily activated by this binding event. Third, this activation must stimulate the transmission or transduction of a signal from the receptor on the cell surface to the nucleus within the cell.

Finally, transcription factors within the nucleus must initiate the transcription of genes involved in cell proliferation. (Transcription is the process by which DNA is converted to RNA. Proteins are then made according to the RNA blueprint, and thus transcription is crucial as the initial step in protein production.) Cells use special proteins and checkpoint signalling systems to ensure that the cell cycle progresses correctly. Checkpoints at the end of G1 and the beginning of G2 are designed to assess DNA damage before and after the S phase. Likewise, a checkpoint during mitosis ensures that the cell’s spindle fibres are properly aligned in metaphase before the chromosomes separate in anaphase.

If DNA damage or spindle formation abnormalities are detected at these checkpoints, the cell is forced to undergo programmed cell death or apoptosis. However, the cell cycle and its checkpoint systems can be sabotaged by defective proteins or genes that cause malignant transformation of the cell, which can lead to cancer. For example, mutations in a protein called p53, which normally detects DNA abnormalities at the G1 checkpoint, may allow cancer-causing mutations to bypass this checkpoint and allow the cell to escape apoptosis.

Cell cycle stages

To divide, a cell must complete several important tasks: It must grow, copy its genetic material (DNA), and physically divide into two daughter cells. Cells perform these tasks in a series of organized and predictable steps that make up the cell cycle. The cell cycle is a cycle, rather than a linear pathway because, at the end of each round, the two daughter cells can start the exact same process from the beginning. In eukaryotic cells or cells with a nucleus, the stages of the cell cycle are divided into two main phases: interphase and the mitotic (M) phase.

  • During interphase, the cell grows and makes a copy of its DNA.
  • During the mitotic (M) phase, the cell separates its DNA into two sets and divides its cytoplasm, forming two new cells.

M phase

During the mitotic (M) phase, the cell splits its copied DNA and cytoplasm to form two new cells. The M phase involves two distinct processes related to division: mitosis and cytokinesis.

In mitosis, the cell’s nuclear DNA condenses into visible chromosomes and is pulled apart by the mitotic spindle, a specialized structure made of microtubules. Mitosis occurs in four stages: prophase (sometimes divided into early prophase and prometaphase), metaphase, anaphase, and telophase. You can learn more about these stages in the video on mitosis.

In cytokinesis, the cytoplasm of the cell splits in two, forming two new cells. Cytokinesis usually begins just as mitosis ends, with a little overlap. Importantly, cytokinesis is carried out differently in animal and plant cells.
Cytokinesis in animal and plant cells.

  • In an animal cell, a contractile ring of cytoskeletal fibres forms in the middle of the cell and contracts inward, producing a cleft called the cleavage furrow. Eventually, the contractile ring pinches the parent cell in two, producing two daughter cells.
  • In a plant cell, vesicles derived from the Golgi apparatus move toward the centre of the cell, where they fuse to form a structure called a cell plate. The cell plate expands outward and connects with the cell’s lateral walls, creating a new cell wall that divides the parent cell to form two daughter cells.

cDNA (Complementary DNA)

(cDNA) Complementary DNA is a double-stranded DNA version of an mRNA molecule. In higher eukaryotes, an mRNA is a more useful predictor of a polypeptide sequence than a genomic sequence, because the introns have been separated. Researchers prefer to use cDNA over mRNA because RNAs are inherently less stable than DNA and techniques to routinely amplify and purify individual RNA molecules do not exist.

cDNA is made from mRNA with the use of a special enzyme called reverse transcriptase, originally isolated from retroviruses. Using an mRNA molecule as a template, reverse transcriptase synthesizes a single-stranded DNA molecule that can then be used as a template for double-stranded DNA synthesis. It is not necessary to cut the cDNA in order to clone it.

DNA: the building block of life

Deoxyribonucleic acid (DNA) is the molecule that carries the instructions for all aspects of an organism’s functions, from growth to metabolism to reproduction. In living organisms, most of the DNA resides in tightly coiled structures called chromosomes, located within the nucleus of each cell. DNA is made up of four different building blocks, called nucleotides, each of which is made up of one of the four nitrogenous bases. These are the purines: guanine (G) and adenine (A), and the pyrimidines: thymine (T) and cytosine (C).

These nucleotides are attached to a deoxyribose sugar and can join other deoxyribose sugars through phosphate bonds to form long chains, some of which can be more than 100,000,000 molecules long. Since each deoxyribose in a DNA strand is attached to one of four nitrogenous bases (G, A, T, or C), these long chains can carry information.

Groups of three nucleotides form the smallest but most well-defined “words” in the language of DNA. These “words” are called codons. Codons are used to request the joining of specific amino acids to form proteins. For example, the adenosine-adenosine-guanosine (AAG) codon requires the amino acid lysine (Lys) to be incorporated into a protein molecule. The AGG codon calls the amino acid arginine (arg). So AAG-AGG would require a lys to be coupled to an arg in a growing protein chain. There are also codons that, under the right circumstances, require a protein to begin to form (start codons) or a protein chain to end (stop codons). As you can see from this simple example, DNA can carry a huge amount of information.

What is genomic and complementary DNA?

The DNA that resides on the chromosomes inside the nucleus, with all the biological information that will be transferred to the next generation, is called genomic DNA (gDNA). The words “genome” and “genomic” come from the word “gene”. A gene is a set of codons that specify a specific protein chain, along with associated start and stop codons. The word genome is an extension of this concept and means the collection of all the genes and other information contained within the nuclei of the cells of an organism. Often when the word “DNA” is used without further clarification, it refers to gDNA.

In nature, the process for information to be transmitted from DNA can occur through gene replication or gene expression. There are some important factors to keep in mind:

  • DNA can copy itself in a process known as replication, using DNA polymerase.
  • Information from DNA passes through messenger RNA (mRNA), which contains sets of four nucleotides (uracil, adenine, guanine, and cytosine).
  • mRNA is produced when enzymes, such as RNA polymerase, bind to specific genes and copy their information into RNA using ribose sugar (not deoxyribose as in DNA). This process is called transcription.
  • Ribosomes assemble around the mRNA, creating a chain of amino acids to create specific proteins. This is called translation.
  • Due to the ribose sugar chains, mRNA is short-lived. It is designed to transmit information from the chromosomes in the nucleus to the machinery that makes proteins.
  • The mRNA rapidly degrades after it has completed its purpose.

Initially, it was observed that gDNA was always read and transcribed into mRNA, which guided protein formation, and was then removed. The notion that information can always flow from DNA to RNA to protein was jokingly called the central dogma of molecular biology.

The functions of gDNA and cDNA

cDNA can be described as gDNA without all the necessary non-coding regions, thus it gets its name as complementary DNA. The main distinction to be made between cDNA and gDNA is the existence of introns and exons. Introns are nucleotides in genes that do not have coding sequences. Introns are usually cleaved or “removed” from RNA in the transcription process before proteins are created. It should be noted that prokaryotes are not capable of splicing introns. Exons are a necessary part of the coding system and are retained after introns are spliced. Extron’s are non-splicing introns, even though they do not contain coding sequences.

When scientists use viral enzymes to make cDNA from RNA isolated from the cells and tissues they are studying, it does not contain introns because it is spliced ​​into mRNA. The cDNA also does not contain any other gDNA that does not directly code for a protein (referred to as non-coding DNA). Lastly, not all genes in gDNA are transcribed into mRNA at any given time. As a result, the cDNA will only contain genes that are actively being used by a specific cell or tissue at any given time. There is much less total information in cDNA than in gDNA, but the information that remains may be much more relevant to what a researcher is looking for since it does not contain sequences that are unnecessary for DNA function and replication.

Once isolated, gDNA can be used to create genomic libraries for DNA sequencing, fingerprinting, differentiation, and other applications in both the clinical and research fields. cDNA can also be used to make cDNA libraries, permanent collections of cDNA that can be copied and/or stored long-term and is commonly used to clone eukaryotic genes into a prokaryote. In this way, a protein expressed in a eukaryotic organism can be introduced into a prokaryote. For this process, cDNA over gDNA is used, since prokaryotes cannot stimulate introns contained in gDNA.

To isolate cDNA, RNA must first be isolated from an organism. Then, using a reverse transcriptase enzyme, cDNA can be produced. This is the process that retroviruses use to incorporate themselves into the cells of their host. Retroviruses, such as simian immunodeficiency virus (SIV) and avian myeloblastosis virus (AMV), use their cDNA to produce mRNA in the host, leading to the production of viral proteins. This is possible because retroviruses use RNA as genomic material instead of DNA, and it is reverse transcribed into cDNA, which then undergoes normal transcription and leads to viral protein in the host.

Custom and pre-made gDNA and cDNA available on BioChain

BioChain provides access to a comprehensive and well-documented tissue bank containing isolated samples that have been tested for contaminants. As part of rigorous quality control, gDNA samples are analyzed by spectrophotometer and electrophoresis, with concentration determined by UV260 measurement and plant concentration determined by green peak measurement. All gDNA is treated with RNase to remove all RNA.

Genomic DNA comes from unique sources, including hundreds of healthy or diseased organ tissues from humans, animals, and plants. gDNA has applications ranging from SNP analysis, methylation studies, copy number variation (CNV) analysis, comparative genomic hybridization (CGH), Southern blotting, next-generation sequencing, and PCR.

Tryptophan Repressor

Abstract

Tryptophan biosynthesis in Escherichia coli is regulated by the trpR gene product, the Gentaur Tryptophan Repressor (Trp). The trp aporepressor binds to the corepressor, L-tryptophan, to form a holopressor complex, which binds tightly to the trp operator DNA and inhibits transcription of the tryptophan biosynthetic operon. The conservation of trp operator sequences among enteric Gram-negative bacteria suggests that trpR genes from other bacterial species can be cloned by complementation in E. coli. To clone trpR homologues, the E. coli trpR gene, delta trpR504, was deleted from a plasmid by site-directed mutagenesis, then crossed into the E. coli genome.

Plasmid clones of Enterobacter aerogenes and Enterobacter cloacae trpR genes were isolated by complementation of the trpR504 delta allele, qualified as the ability to repress beta-galactosidase synthesis from a prophage-transmitted trpE-lacZ gene fusion. The predicted amino acid sequences of four enteric TrpR proteins show differences, clustered at the back of the folded repressor, versus DNA-binding helix-turn-helix substructures.

These differences are predicted to have little effect on interactions of aporepressor with tryptophan, holorepressor with operator DNA, or holorepressor dimers linked in tandem with each other. Although some variation in the dimer interface is observed, the interactions expected to stabilize the interface are preserved. The phylogenetic relationships revealed by the TrpR amino acid sequence alignment are consistent with the results of others.

In E. coli, the synthesis of the amino acid tryptophan from precursors available to the cell requires 5 enzymes. The genes that encode them are grouped into a single operon with its own promoter and operator. When tryptophan is available to the cell, its presence turns off the operon.

Mechanism

  • One tryptophan molecule binds to one site on each Trp repressor monomer.
  • The Trp repressor, a homodimer of two of these complexes, binds to the operator of the Trp operon.
  • This stops the transcription of all 5 genes in the operon, so the enzymes used in Trp synthesis are not synthesized.

This stereoscopic view () shows the tryptophan repressor (right side of each panel) bound to its operator DNA (left side). The two identical repressor polypeptides are shown on either side of the horizontal red line. The two tryptophan molecules are shown as red rings. Also, look for the alpha-helix stretches in each monomer. You may find it easier to merge the two images into a 3D view by holding an 8.5 x 11″ (22 x 28 cm) sheet of paper vertically between your nose and the dividing line between the two images on the screen so that your left eye sees only the image on the left, his right eye only the right.

Sensitive and Specific Cadmium Biosensor Developed by Reconfiguring Metal Transport and Leveraging Natural Gene Repositories

Sensitive and Specific Cadmium Biosensor Developed by Reconfiguring Metal Transport and Leveraging Natural Gene Repositories

Whole-cell biosensors are helpful for monitoring heavy steel toxicity in public well being and ecosystems, however their improvement has been hindered by intrinsic trade-offs between sensitivity and specificity. Here, we demonstrated an efficient engineering resolution by constructing a delicate, particular, and high-response biosensor for carcinogenic cadmium ions. We genetically programmed the steel transport system of Escherichia coli to complement intracellular cadmium ions and deprive interfering steel species. We then chosen 16 cadmium-sensing transcription components from the GenBank database and examined their reactivity to 14 steel ions within the engineered E. coli utilizing the expression of the inexperienced fluorescent protein because the readout.

The ensuing cadmium biosensor was extremely particular and confirmed a detection restrict of three nM, a linear improve in fluorescent intensities from zero to 200 nM, and a maximal 777-fold sign change. Using this whole-cell biosensor, a smartphone, and low-tech gear, we developed a easy assay able to measuring cadmium ions on the similar focus vary in irrigation water and human urine. This technique is user-friendly and cost-effective, making it inexpensive to display screen massive quantities of samples for cadmium toxicity in agriculture and medication. Moreover, our work highlights pure gene repositories as a treasure chest for bioengineering.

Promise and challenges of dystonia mind banking: establishing a human tissue repository for research of X-Linked Dystonia-Parkinsonism

X-Linked Dystonia-Parkinsonism (XDP) is a neurodegenerative illness affecting people with ancestry to the island of Panay within the Philippines. In latest years there was appreciable progress at elucidating the genetic foundation of XDP and candidate illness mechanisms in patient-derived mobile fashions, however the neural substrates that give rise to XDP in vivo are nonetheless poorly understood. Previous research of restricted XDP postmortem mind samples have reported a selective dropout of medium spiny neurons throughout the striatum, though neuroimaging of XDP sufferers has detected extra abnormalities in a number of mind areas past the basal ganglia.

Given the necessity to totally outline the CNS constructions which are affected on this illness, we created a mind financial institution in Panay to function a tissue useful resource for detailed research of XDP-related neuropathology. The outcomes point out that this pipeline preserves tissue integrity to an extent suitable with a variety of morphologic, molecular, and biochemical analyses. Thus the algorithms that we developed for working in rural communities might function a information for establishing related mind banks for different uncommon illnesses in indigenous populations.

Here we describe this platform, from donor recruitment and consent to tissue assortment, processing, and storage, that was assembled inside a predominantly rural area of the Philippines with restricted entry to medical and laboratory services. Thirty-six brains from XDP people have been collected over an preliminary four years interval. Tissue high quality was assessed primarily based on histologic staining of cortex, RNA integrity scores, detection of neuronal transcripts in situ by fluorescent hybridization chain response, and western blotting of neuronal and glial proteins.

Sensitive and Specific Cadmium Biosensor Developed by Reconfiguring Metal Transport and Leveraging Natural Gene Repositories

Cost per response evaluation of repository corticotropin injection versus different various therapies for acute exacerbations of a number of sclerosis

Relapses are widespread in sufferers with a number of sclerosis (MS) even after using disease-modifying therapies. Repository corticotropin injection (RCI), plasmapheresis (PMP), and intravenous immunoglobulin (IVIg) could also be utilized as various therapies within the administration of MS relapse. There is an absence of well being financial research on these various therapies for the acute exacerbations of MS. The goal of this research was to estimate the fee per response of RCI in contrast with PMP or IVIg from the United States (US) business payer perspective. Costs and response charges have been sourced from printed peer-reviewed observational research.
The value per response for every therapy was calculated by dividing the overall annual value of care by the proportion of sufferers with resolved relapse for every therapy. The incremental value per response ratio was calculated by dividing the distinction in prices and the proportion of responses for RCI versus PMP or IVIg. One-way sensitivity evaluation (OWSA) was performed for each prices and response charges. All included prices have been inflated to the 2019 US {dollars}. With a decrease complete annual value of care and a better response fee, RCI had a decrease value per response (US$141,970) in contrast with PMP or IVIg (US$253,331). RCI had a decrease value per response even when extra stringent estimates for RCI have been utilized within the OWSA. The annual value of care had a larger affect on the fee per response within the OWSA.

Rat GTRAP41 Control/blocking peptide

GTRAP41-P 100 ug
EUR 196.8

Rat GTRAP48 Control/blocking peptide

GTRAP48-P 100 ug
EUR 196.8

Rat UT2 Control/blocking peptide #1

RUT21-P 100 ug
EUR 196.8

Rat AVP V1b Control/blocking peptide

AVP1B13-P 100 ug
EUR 196.8

Rat AVP-V2 Control/blocking peptide

AVPV21-P 100 ug
EUR 196.8

Rat EAAT4 Control/blocking peptide #1

EAAT41-P 100 ug
EUR 196.8

Rat Amylin Control/blocking peptide # 3

AMYL13-P 100 ug
EUR 196.8

Rat Nephrin Control/blocking peptide #1

NPHN11-P 100 ug
EUR 196.8

Rat neurofascin (Nfasc)-control Control/blocking peptide

AB-23249-CP 100ug
EUR 196.8

Rat Syntenin Control/blocking peptide #1

SDB11-P 100 ug
EUR 196.8

Rat Bin 1b Control/blocking peptide #1

BIN1B11-P 100 ug
EUR 196.8

Rat AVP V1a Control/blocking peptide # 1

AVP1A11-P 100 ug
EUR 196.8

Rat AVP V1a Control/blocking peptide # 2

AVP1A12-P 100 ug
EUR 196.8

Rat Akt-2 Control/blocking peptide #1

AKT21-P 100 ug
EUR 196.8

Rat Akt-3 Control/blocking peptide #1

AKT31-P 100 ug
EUR 196.8

Control/Blocking peptide CD40

CD4011-C 100 ug
EUR 196.8

Mouse CABP9K (D9K/CALB3 or CABP1) Control/blocking peptide #1

D9K11-P 100 ug
EUR 196.8

Human CABP9K (D9K/CALB3 or CABP1) Control/blocking peptide #2

D9K12-P 100 ug
EUR 196.8

Control/Blocking peptide EOMES

EMS11-C 100 ug
EUR 196.8

NET-5 Blocking Peptide

DF8578-BP 1mg
EUR 234

Rat FAS Ligand Control/blocking peptide #1

FASL11-P 100 ug
EUR 196.8

Rat EAAC1/EAAT3 Control/blocking peptide #1

EAAC11-P 100 ug
EUR 196.8

Rat DRASIC/ASIC3 Control/blocking peptide #1

DRASIC31-P 100 ug
EUR 196.8

Rat MDEG2/ASIC2b Control/blocking peptide #1

MDEG21-P 100 ug
EUR 196.8

Rat Urotensin 2 Control/blocking peptide # 1

UT21-P 100 ug
EUR 196.8

Rat Connexin 30.3 (Cx30.3) Control/blocking peptide

CX303-P 100 ug
EUR 196.8

Rat Connexin 31.1 (Cx31.1) Control/blocking peptide

CX311-P 100 ug
EUR 196.8

Rat Neuromedin U control/blocking peptide # 2

NMU51-P 100 ug
EUR 196.8

Rat Aquaporin 3 (AQP3) Control/blocking peptide

AQP31-P 100 ug
EUR 196.8

Rat/human Oxytocin Control/blocking peptide #1

OT15-P 100 ug
EUR 196.8

Rat Exchange inhibitory peptide (XIP) Control/blocking peptide #1

XIP11-P 100 ug
EUR 196.8

Rat ASIC4/BNAC4/SPASIC Control/blocking peptide

ASIC41-P 100 ug
EUR 196.8

Rat/human Akt-1 Control/blocking peptide #4

AKT14-P 100 ug
EUR 196.8

NET (pS357) Blocking Peptide

20-abx062104
  • EUR 376.80
  • EUR 610.80
  • 1 mg
  • 5 mg

Rat Oxytocin Receptor Control/blocking peptide #1

OTR11-P 100 ug
EUR 196.8

Rat Synuclein-alpha Control/blocking peptide # 2

SYN12-P 100 ug
EUR 196.8

Rat ER Beta 1/2 Control/blocking peptide #2

ERB12-P 100 ug
EUR 196.8

Human, mouse, rat connexin 43 and 37 hemi-channel blocking peptide (GAP27 domain with conserved sequence SRPTEK)

Cx2703-P-1 1 mg
EUR 315.6

Human, mouse, rat connexin 43 and 37 hemi-channel blocking peptide (GAP27 domain with conserved sequence SRPTEK)

Cx2703-P-5 5 mg
EUR 927.6

Rat GABAb-R2 (GBR2) Control/blocking peptide #1

GBR21-P 100 ug
EUR 196.8

Rat GABAb-R2 (GBR2) Control/blocking peptide #2

GBR22-P 100 ug
EUR 196.8

Rat Connexin 32 (Cx32) Control/blocking peptide # 1

CX32A11-P 100 ug
EUR 196.8

Rat Connexin 32 (Cx32) Control/blocking peptide # 2

CX32B12-P 100 ug
EUR 196.8

Rat Connexin 32 (Cx32) Control/blocking peptide # 3

CX32C13-P 100 ug
EUR 196.8

Rat Connexin 37 (Cx37) Control/blocking peptide # 2

Cx37B12-P 100 ug
EUR 196.8

Rat Connexin 40 (Cx40) Control/blocking peptide #2

Cx40B12-P 100 ug
EUR 196.8

Rat Connexin 46 (Cx46) Control/blocking peptide #1

Cx46-P 100 ug
EUR 196.8

Rat/Human Orexin-A Control/blocking peptide # 1

OXA11-P 100 ug
EUR 196.8

Rat Proline transporter Control/blocking peptide #1

PROL11-P 100 ug
EUR 196.8

Mouse Peptide YY (PYY) control/blocking peptide # 1

PYY11-P 100 ug
EUR 196.8

Mouse AQP12 control/blocking peptide

AQP125-P 100 ug
EUR 182.4

Human Livin Control/blocking peptide

LIVN11-P 100 ug
EUR 196.8

Rat Aquaporin 1 (AQP1) Control/blocking peptide #1

AQP11-P 100 ug
EUR 196.8

Rat Aquaporin 1 (AQP1) Control/blocking peptide #1

AQP12-P 100 ug
EUR 196.8

Rat Aquaporin 2 (AQP2) Control/blocking peptide #1

AQP21-P 100 ug
EUR 196.8

Rat Aquaporin 2 (AQP2) Control/blocking peptide #2

AQP22-P 100 ug
EUR 196.8

Rat Aquaporin 4 (AQP4) Control/blocking peptide #1

AQP41-P 100 ug
EUR 196.8

Rat Aquaporin 5 (AQP5) Control/blocking peptide #1

AQP51-P 100 ug
EUR 196.8

Rat Aquaporin 7 (AQP7) Control/blocking peptide # 1

AQP71-P 100 ug
EUR 196.8

Rat Aquaporin 7 (AQP7)Control/blocking peptide # 2

AQP72-P 100 ug
EUR 196.8

Rat Aquaporin 8 (AQP8) Control/blocking peptide #1

AQP81-P 100 ug
EUR 196.8

Rat Aquaporin 8 (AQP8) Control/blocking peptide # 2

AQP82-P 100 ug
EUR 196.8

Rat Aquaporin 9 (AQP9) Control/blocking peptide #1

AQP91-P 100 ug
EUR 196.8

Rat Aquaporin 9 (AQP9) Control/blocking peptide # 2

AQP92-P 100 ug
EUR 196.8

Rat Adipsin/Factor D control/blocking peptide # 1

ADN11-P 100 ug
EUR 196.8

Rat GABAb-R1a (GBR1a) Control/blocking peptide #1

GBR1A11-P 100 ug
EUR 196.8

Rat GABAb-R1b (GBR1b) Control/blocking peptide #1

GBR1B11-P 100 ug
EUR 196.8

Rat Dopamine Transporter Control/blocking peptide # 1

DAT11-P 100 ug
EUR 196.8

Rat Taurine Transporter (TAU) Control/blocking peptide

TAU11-P 100 ug
EUR 196.8

Mouse Agouti Control/blocking peptide

AGO11-P 100 ug
EUR 196.8

Human CYP1B1 control/blocking peptide

CYP1B11-P 100 ug
EUR 196.8

Mouse CYP1B1 control/blocking peptide

CYP1B12-P 100 ug
EUR 196.8

Mouse Moesin control/blocking peptide

MSN11-P 100 ug
EUR 196.8

Mouse Klotho Control/blocking peptide

KL11-P 100 ug
EUR 196.8

Human Parkin Control/blocking peptide

PARK11-P 100 ug
EUR 196.8

Human Sialin control/blocking peptide

SIAL11-P 100 ug
EUR 196.8

Rat MDEG1/ASIC2a/BNaC1 Control/blocking peptide #1

MDEG11-P 100 ug
EUR 196.8

Human Barttin Control/blocking peptide

BRTN11-P 100 ug
EUR 196.8

Human Iceberg control (blocking) peptide

ICEBERG11-P 100 ug
EUR 196.8

Rat Androgen Receptor (AR) Control/blocking peptide #1

AR11-P 100 ug
EUR 196.8

Rat neurofascin (Nfasc)-phosphor Control/blocking peptide

AB-23249-P 100ug
EUR 196.8

Human HE2 Control/blocking peptide #1

HE21-P 100 ug
EUR 196.8

Rat GABA Transporter (GAT1) Control/blocking peptide #1

GAT11-P 100 ug
EUR 196.8

Rat GABA Transporter (GAT2) Control/blocking peptide #1

GAT21-P 100 ug
EUR 196.8

Rat GABA Transporter (GAT3) Control/blocking peptide #1

GAT31-P 100 ug
EUR 196.8

Control/Blocking peptide Human BCL-2

BCL11-C 100 ug
EUR 196.8

Control/Blocking peptide Mouse BCL-2

BCL21-C 100 ug
EUR 196.8

Human Aven Control/blocking peptide # 1

AVEN11-P 100 ug
EUR 196.8

Mouse Aven Control/blocking peptide # 2

AVEN12-P 100 ug
EUR 196.8

Human MOP3 Control/blocking peptide #1

MOP31-P 100 ug
EUR 182.4

Human MOP4 Control/blocking peptide #1

MOP41-P 100 ug
EUR 196.8

Human MOP4 Control/blocking peptide #2

MOP42-P 100 ug
EUR 196.8

Human MutY Control/blocking peptide #1

MUTY11-P 100 ug
EUR 196.8

Human KST1 Control/blocking peptide # 1

KST11-P 100 ug
EUR 196.8

Mouse Per1 Control/blocking peptide #1

PER11-P 100 ug
EUR 196.8

Human Per1 Control/blocking peptide #2

PER12-P 100 ug
EUR 196.8

Mouse Per2 Control/blocking peptide #1

PER21-P 100 ug
EUR 196.8

Mouse Per3 Control/blocking peptide #1

PER31-P 100 ug
EUR 196.8

Mouse Clock Control/blocking peptide # 1

CLO11-P 100 ug
EUR 196.8

Human Clock Control/blocking peptide # 2

CLO12-P 100 ug
EUR 196.8

Human EAAT5 Control/blocking peptide #1

EAAT51-P 100 ug
EUR 196.8

Rat ATII, Type 1 receptor Control/blocking peptide # 1

AT11-P 100 ug
EUR 196.8

Rat ATII, Type 1 receptor Control/blocking peptide # 2

AT12-P 100 ug
EUR 196.8

Rat Na-H Exchanger 3 (NHE3) Control/blocking peptide

NHE32-P 100 ug
EUR 196.8

Rat NMU receptor 1 (NMUR1) control/blocking peptide # 1

NMUR11-P 100 ug
EUR 196.8

Rat NMU receptor 2 (NMUR2) control/blocking peptide # 2

NMUR22-P 100 ug
EUR 196.8

Rat Heme Oxygenase 1 (HO-1) Control/blocking peptide

HO11-P 100 ug
EUR 196.8

Rat Heme Oxygenase 3 (HO-3) Control/blocking peptide

HO31-P 100 ug
EUR 196.8

Rat Taste Receptor 1 (TR1) Control/blocking peptide #1

TR11-P 100 ug
EUR 196.8

Rat Taste Receptor 2 (TR2) Control/blocking peptide #1

TR21-P 100 ug
EUR 196.8

Human Amylin Control/blocking peptide # 2

AMYL12-P 100 ug
EUR 196.8

Mouse Leptin Control/blocking peptide # 1

OB11-P 100 ug
EUR 196.8

Mouse Leptin Control/blocking peptide # 2

OB12-P 100 ug
EUR 196.8

Human NHERF1 Control/blocking peptide #1

NHERF11-P 100 ug
EUR 196.8

Human NHERF2 Control/blocking peptide #1

NHERF21-P 100 ug
EUR 196.8

Hev-b1 Control/blocking peptide (HEVB11)

HEVB11-P 100 ug
EUR 196.8

Control/Blocking peptide for Human WNT5a

WNT511-P 100 ug
EUR 196.8

Rat Cannabinoid receptor (CB1) Control/blocking peptide # 2

CB12-P 100 ug
EUR 196.8

Rat Cannabinoid receptor (CB2) Control/blocking peptide # 2

CB22-P 100 ug
EUR 196.8

Rat Anion Exchanger 2 (AE2) Control/blocking peptide #2

AE21-P 100 ug
EUR 196.8

Rat Anion Exchanger 3 (AE3) Control/blocking peptide #1

AE31-P 100 ug
EUR 196.8

Human CYP26A1 control/blocking peptide #1

CYP26A11-P 100 ug
EUR 196.8

Human CYP26A1 control/blocking peptide #2

CYP26A12-P 100 ug
EUR 196.8

Human Motilin control/blocking peptide # 1

MOTL11-P 100 ug
EUR 196.8

Human Podocin Control/blocking peptide #1

PODO11-P 100 ug
EUR 196.8

Human Ghrelin control/blocking peptide # 1

GHS11-P 100 ug
EUR 196.8

Human Ghrelin control/blocking peptide # 2

GHS12-P 100 ug
EUR 196.8

Human Galanin Control/blocking peptide # 1

GAL51-P 100 ug
EUR 196.8

Rat transferrin receptor 2 (Tfr2) Control/blocking peptide

AB-23099-P 100ug
EUR 196.8

Rat transferrin receptor 2 (Tfr2) Control/blocking peptide

AB-23100-P 100ug
EUR 196.8

Mouse/rat Aquaporin 2 (AQP2) Control/blocking peptide # 3

AQP23-P 100 ug
EUR 196.8

Mouse/Human AQP11 control/blocking peptide

AQP115-P 100 ug
EUR 182.4

Drosophila Per Control/blocking peptide #2

PER15-P 100 ug
EUR 196.8

Rat Serotonin Transporter (SERT) Control/blocking peptide #1

SERT11-P 100 ug
EUR 196.8

Rat Dopamine Receptor 1(D1R) Control/blocking peptide # 1

D1R11-P 100 ug
EUR 196.8

Rat Dopamine Receptor 1(D1R) Control/blocking peptide # 2

D1R12-P 100 ug
EUR 196.8

Rat Dopamine Receptor 3 (D3R) Control/blocking peptide # 2

D3R12-P 100 ug
EUR 196.8

Rat Dopamine Receptor 5 (D5R) Control/blocking peptide # 2

D5R12-P 100 ug
EUR 196.8

Rat Chloride channel 1 (CLC1) Control/blocking peptide # 1

CLC11-P 100 ug
EUR 196.8

Rat Chloride channel 1 (CLC1) Control/blocking peptide # 2

CLC12-P 100 ug
EUR 196.8

Rat Chloride channel 2 (CLC2) Control/blocking peptide # 1

CLC21-P 100 ug
EUR 196.8

Rat Chloride channel 3 (CLC3) Control/blocking peptide #1

CLC31-P 100 ug
EUR 196.8

Rat Chloride channel 4 (CLC4) Control/blocking peptide #1

CLC41-P 100 ug
EUR 196.8

Rat Chloride channel 5 (CLC5) Control/blocking peptide #1

CLC51-P 100 ug
EUR 196.8

Rat Chloride channel 6 (CLC6) Control/blocking peptide #1

CLC61-P 100 ug
EUR 196.8

Rat Chloride channel 7 (CLC7) Control/blocking peptide #1

CLC71-P 100 ug
EUR 196.8

Rat Orexin-1 Receptor (OX1R) Control/blocking peptide # 1

OX1R11-P 100 ug
EUR 196.8

Rat Orexin-2 Receptor (OX2R) Control/blocking peptide #1

OX2R21-P 100 ug
EUR 196.8

Rat ghrelin receptor (GHS-R) Control/blocking peptide # 1

GHSR11-P 100 ug
EUR 196.8

Human ice Protease-Activating Factor (IPAF) or CARD12 Control/blocking peptide

IPAF11-P 100 ug
EUR 196.8

Drosophila BMAL Control/blocking peptide # 1

BMALD11-P 100 ug
EUR 196.8

Human Nicastrin control (blocking) peptide #1

NICN11-P 100 ug
EUR 196.8

Drosophila Per1 Control/blocking peptide # 1

PER14-P 100 ug
EUR 196.8

Human Tankyrase Control/blocking peptide #1

TANK11-P 100 ug
EUR 196.8
Based on the estimates from the real-world proof, our financial analysis means that RCI might have real-world medical and financial advantages for sufferers with MS relapse who fail on corticosteroid remedy. Repository corticotropin injection (RCI; Acthar® Gel) is indicated to induce a diuresis or a remission of proteinuria in nephrotic syndrome (NS) with out uremia of the idiopathic kind or that as a result of lupus erythematosus. This research compares affected person traits and measurable healthcare useful resource utilization (HCRU) between NS sufferers who acquired a prescription for RCI and then have been both accepted or denied therapy by their insurers.

Acthar® Gel (repository corticotropin injection) dose-response relationships in an animal model of epileptic spasms

Acthar® Gel (repository corticotropin injection) dose-response relationships in an animal model of epileptic spasms

Studies have been undertaken to judge the effectiveness of Acthar® Gel (repository corticotropin injection [RCI]) in the tetrodotoxin (TTX) model of early-life-induced epileptic spasms. Repository corticotropin injection (RCI) is broadly used in the United States to deal with childish spasms. A serious element of RCI is N25 deamidated ACTH. Additionally, we hoped to supply some perception into the attainable function circulating corticosteroids play in spasm cessation by evaluating the RCI dose-response relationships for spasm suppression to RCI-induced corticosterone launch from the adrenal gland. Spasms have been induced by persistent TTX infusion into the neocortex starting on postnatal day 11.

Repository corticotropin injection (RCI) dosages have been between Eight and 32 IU/kg/day. Drug titration protocols have been used, and comparisons have been made to injections of a automobile gel. Video/EEG recordings (24/7) monitored the drug’s results repeatedly for as much as 2 months. Tetrodotoxin (TTX)-infused management rats have been monitored for a similar interval of time. In separate experiments, the identical dosages of RCI got to rats and 1 h later plasma was collected and assayed for corticosterone. The value of care included MS-related inpatient, outpatient, and remedy prices. Treatment response was outlined as no proof of extra relapse therapy or process claims inside 30 days after therapy.

A parallel examine in contrast the consequences of 1-day and 10-day RCI remedies on circulating corticosterone. Results confirmed that RCI was ineffective at dosages of 8, 12, and 16 IU/kg/day however eradicated spasms in 66% of animals handled with 24 or 32 IU/kg/day. Treating animals with 32 IU/kg/day alone produced the identical diploma of spasms suppression as noticed throughout the titration protocols. In rats that had hypsarrhythmia-like exercise, RCI eradicated this irregular interictal EEG sample in all rats that grew to become seizure-free. In phrases of plasma corticosterone, 1- and 10-day remedies with RCI produced comparable will increase in this hormone and the degrees elevated linearly with rising dosages of RCI.

This stood in sharp distinction to the sigmoid-like dose-response curve for decreases in spasm counts. Our outcomes additional validate the TTX model as related for the examine of childish spasms. The model ought to be helpful for investigating how RCI acts to get rid of seizures and hypsarrhythmia. Dose-response outcomes recommend that both very excessive concentrations of circulating corticosteroids are required to abolish spasms or RCI acts by a distinct mechanism. In the oblique remedy comparability of six eligible scientific trial research, the chances of attaining efficacy outcomes have been 5 to eight instances larger with RCI than with tetracosactide and 14 to 16 instances larger than CCMC.

A Systematic Literature Review and Indirect Treatment Comparison of Efficacy of Repository Corticotropin Injection versus Synthetic Adrenocorticotropic Hormone for Infantile Spasms

Infantile spasms is a uncommon illness characterised by distinct seizures and hypsarrhythmia. Adrenocorticotropic hormone (ACTH) is on the market as a pure product (repository corticotropin injection, [RCI]; Acthar® Gel) and as artificial analogs. RCI is a naturally-sourced advanced combination of purified ACTH analogs and different pituitary peptides accredited by the United States Food and Drug Administration as a monotherapy for the remedy of childish spasms. RCI is usually used in the United States. Outside the United States, artificial analogs of ACTH-synthetic ACTH1-24 (tetracosactide) and artificial ACTH1-39 (corticotropin carboxymethyl-cellulose [CCMC])-are used.

The efficacy of RCI could differ from that of artificial ACTH remedies primarily based on the construction of peptide; nonetheless, no head-to-head scientific trials have in contrast the efficacy of RCI and artificial ACTH remedies. A scientific overview and oblique remedy comparability of scientific trials was carried out to evaluate the comparative efficacy of RCI and artificial ACTH remedies in childish spasms.

A search was carried out in MEDLINE, EMBASE, and Cochrane databases by September 30, 2020. Relevant scientific trials on RCI or artificial ACTH remedy and reporting both cessation of spasms or decision of hypsarrhythmia, individually or as a mixed final result have been included. A Bayesian oblique remedy comparability utilizing a fixed-effects model was used for comparative efficacy. Of 473 citations screened, 21 research have been reviewed qualitatively. This translated to a threat discount of 10% to 14% and 40% to 50% with RCI versus tetracosactide and CCMC, respectively.

For each two to 5 sufferers handled, RCI improved efficacy outcomes in one extra affected person in comparison with artificial ACTH (adjusted quantity needed-to-treat).Based on the out there restricted proof, outcomes recommend RCI could also be extra efficacious for childish spasms than artificial ACTH remedies. Our findings present a blueprint to tell the design of future potential research for the remedy of childish spasms.

Acthar® Gel (repository corticotropin injection) dose-response relationships in an animal model of epileptic spasms

Quality evaluation of real-world knowledge repositories throughout the info life cycle: A literature overview

Data high quality (DQ) have to be constantly outlined in context. The attributes, metadata, and context of longitudinal real-world knowledge (RWD) haven’t been formalized for high quality enchancment throughout the info manufacturing and curation life cycle. We sought to finish a literature overview on DQ evaluation frameworks, indicators and instruments for analysis, public well being, service, and high quality enchancment throughout the info life cycle. The overview adopted PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) pointers.
Databases from well being, bodily and social sciences have been used: Cinahl, Embase, Scopus, ProQuest, Emcare, PsycINFO, Compendex, and Inspec. Embase was used as an alternative of PubMed (an interface to go looking MEDLINE) as a result of it consists of all MeSH (Medical Subject Headings) phrases used and journals in MEDLINE in addition to extra distinctive journals and convention abstracts. A mixed knowledge life cycle and high quality framework guided the search of revealed and grey literature for DQ frameworks, indicators, and instruments. At least 2 authors independently recognized articles for inclusion and extracted and categorized DQ ideas and constructs. All authors mentioned findings iteratively till consensus was reached.

AAV2-LacZ Control Virus

AAV-342 50 ?L
EUR 1221.6
Description: LacZ control virus of AAV serotype 2.

AAV1-Luc Control Virus

AAV-321 50 ?L
EUR 1221.6
Description: Luciferase control virus of AAV serotype 1.

AAV3-Luc Control Virus

AAV-323 50 ?L
EUR 1221.6
Description: Luciferase control virus of AAV serotype 3.

AAV4-Luc Control Virus

AAV-324 50 ?L
EUR 1221.6
Description: Luciferase control virus of AAV serotype 4.

AAV5-Luc Control Virus

AAV-325 50 ?L
EUR 1221.6
Description: Luciferase control virus of AAV serotype 5.

AAV6-Luc Control Virus

AAV-326 50 ?L
EUR 1221.6
Description: Luciferase control virus of AAV serotype 6.

AAV1 Null Control Virus

AAV-351 50 ?L
EUR 1221.6
Description: Null (empty) control virus of AAV serotype 1.

AAV3 Null Control Virus

AAV-353 50 ?L
EUR 1221.6
Description: Null (empty) control virus of AAV serotype 3.

AAV4 Null Control Virus

AAV-354 50 ?L
EUR 1221.6
Description: Null (empty) control virus of AAV serotype 4.

AAV5 Null Control Virus

AAV-355 50 ?L
EUR 1221.6
Description: Null (empty) control virus of AAV serotype 5.

AAV6 Null Control Virus

AAV-356 50 ?L
EUR 1221.6
Description: Null (empty) control virus of AAV serotype 6.

AAV1-GFP Control Virus

AAV-301 50 ?L
EUR 1221.6
Description: GFP control virus of AAV serotype 1.

AAV3-GFP Control Virus

AAV-303 50 ?L
EUR 1221.6
Description: GFP control virus of AAV serotype 3.

AAV4-GFP Control Virus

AAV-304 50 ?L
EUR 1221.6
Description: GFP control virus of AAV serotype 4.

AAV5-GFP Control Virus

AAV-305 50 ?L
EUR 1221.6
Description: GFP control virus of AAV serotype 5.

AAV6-GFP Control Virus

AAV-306 50 ?L
EUR 1221.6
Description: GFP control virus of AAV serotype 6.

AAV1-Cre Control Virus

AAV-311 50 ?L
EUR 1221.6
Description: Cre control virus of AAV serotype 1.

AAV3-Cre Control Virus

AAV-313 50 ?L
EUR 1221.6
Description: Cre control virus of AAV serotype 3.

AAV4-Cre Control Virus

AAV-314 50 ?L
EUR 1221.6
Description: Cre control virus of AAV serotype 4.

AAV5-Cre Control Virus

AAV-315 50 ?L
EUR 1221.6
Description: Cre control virus of AAV serotype 5.

AAV6-Cre Control Virus

AAV-316 50 ?L
EUR 1221.6
Description: Cre control virus of AAV serotype 6.

AAV1-LacZ Control Virus

AAV-341 50 ?L
EUR 1221.6
Description: LacZ control virus of AAV serotype 1.

AAV3-LacZ Control Virus

AAV-343 50 ?L
EUR 1221.6
Description: LacZ control virus of AAV serotype 3.

AAV4-LacZ Control Virus

AAV-344 50 ?L
EUR 1221.6
Description: LacZ control virus of AAV serotype 4.

AAV5-LacZ Control Virus

AAV-345 50 ?L
EUR 1221.6
Description: LacZ control virus of AAV serotype 5.

AAV6-LacZ Control Virus

AAV-346 50 ?L
EUR 1221.6
Description: LacZ control virus of AAV serotype 6.

Lenti-III-PGK-Luc Control Virus

LV088 4 x 500 ul
EUR 195

saCas9 Nuclease AAV Virus (AAV2)

K209 2 x 250 µl, 1 x 10^9 GC/ml, Titer: 1 x 10^9 GC/ml
EUR 375
Description: This AAV vector expresses the Cas9 orthologue from Staphylococcus Aureus (saCas9). saCas9 is ~1 kb shorter than spCas9, allowing it to be efficiently packaged in AAV Virus. Furthermore, the saCas9 enzyme recognizes a longer PAM sequence than spCas9, and thus has greater editing specificity.AAV has low immunogenicity and broad host range, making it an ideal choice for both in vivo and in vitro applications. Use this saCas9-expressing AAV virus with a target-specific saCas9-compatible sgRNA for highly specific and efficient genome editing.

scAAV1-GFP Control Virus

AAV-331 50 ?L
EUR 1221.6
Description: Self-complementary GFP control virus of AAV serotype 1.

scAAV2-GFP Control Virus

AAV-332 50 ?L
EUR 1221.6
Description: Self-complementary GFP control virus of AAV serotype 2.

scAAV3-GFP Control Virus

AAV-333 50 ?L
EUR 1221.6
Description: Self-complementary GFP control virus of AAV serotype 3.

scAAV4-GFP Control Virus

AAV-334 50 ?L
EUR 1221.6
Description: Self-complementary GFP control virus of AAV serotype 4.

scAAV5-GFP Control Virus

AAV-335 50 ?L
EUR 1221.6
Description: Self-complementary GFP control virus of AAV serotype 5.

scAAV6-GFP Control Virus

AAV-336 50 ?L
EUR 1221.6
Description: Self-complementary GFP control virus of AAV serotype 6.

Rat Adeno Associated Virus type 2 Antibody (AAV2-Ab) ELISA kit

E02A0397-192T 192 tests
EUR 1524
Description: A competitive ELISA for quantitative measurement of Rat Adeno Associated Virus type 2 Antibody (AAV2-Ab) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Rat Adeno Associated Virus type 2 Antibody (AAV2-Ab) ELISA kit

E02A0397-48 1 plate of 48 wells
EUR 624
Description: A competitive ELISA for quantitative measurement of Rat Adeno Associated Virus type 2 Antibody (AAV2-Ab) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Rat Adeno Associated Virus type 2 Antibody (AAV2-Ab) ELISA kit

E02A0397-96 1 plate of 96 wells
EUR 822
Description: A competitive ELISA for quantitative measurement of Rat Adeno Associated Virus type 2 Antibody (AAV2-Ab) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Pig Adeno Associated Virus type 2 Antibody (AAV2-Ab) ELISA kit

E07A0397-192T 192 tests
EUR 1524
Description: A competitive ELISA for quantitative measurement of Porcine Adeno Associated Virus type 2 Antibody (AAV2-Ab) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Pig Adeno Associated Virus type 2 Antibody (AAV2-Ab) ELISA kit

E07A0397-48 1 plate of 48 wells
EUR 624
Description: A competitive ELISA for quantitative measurement of Porcine Adeno Associated Virus type 2 Antibody (AAV2-Ab) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Pig Adeno Associated Virus type 2 Antibody (AAV2-Ab) ELISA kit

E07A0397-96 1 plate of 96 wells
EUR 822
Description: A competitive ELISA for quantitative measurement of Porcine Adeno Associated Virus type 2 Antibody (AAV2-Ab) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Dog Adeno Associated Virus type 2 Antibody (AAV2-Ab) ELISA kit

E08A0397-192T 192 tests
EUR 1524
Description: A competitive ELISA for quantitative measurement of Canine Adeno Associated Virus type 2 Antibody (AAV2-Ab) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Dog Adeno Associated Virus type 2 Antibody (AAV2-Ab) ELISA kit

E08A0397-48 1 plate of 48 wells
EUR 624
Description: A competitive ELISA for quantitative measurement of Canine Adeno Associated Virus type 2 Antibody (AAV2-Ab) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Dog Adeno Associated Virus type 2 Antibody (AAV2-Ab) ELISA kit

E08A0397-96 1 plate of 96 wells
EUR 822
Description: A competitive ELISA for quantitative measurement of Canine Adeno Associated Virus type 2 Antibody (AAV2-Ab) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Rat Adeno Associated Virus type 2 Antibody (AAV2-Ab) Elisa kit

E01A8879 96T
EUR 700
Description: ELISA

Goat Adeno Associated Virus type 2 Antibody (AAV2-Ab) ELISA kit

E06A0397-192T 192 tests
EUR 1524
Description: A competitive ELISA for quantitative measurement of Goat Adeno Associated Virus type 2 Antibody (AAV2-Ab) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Goat Adeno Associated Virus type 2 Antibody (AAV2-Ab) ELISA kit

E06A0397-48 1 plate of 48 wells
EUR 624
Description: A competitive ELISA for quantitative measurement of Goat Adeno Associated Virus type 2 Antibody (AAV2-Ab) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Goat Adeno Associated Virus type 2 Antibody (AAV2-Ab) ELISA kit

E06A0397-96 1 plate of 96 wells
EUR 822
Description: A competitive ELISA for quantitative measurement of Goat Adeno Associated Virus type 2 Antibody (AAV2-Ab) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Goat Adeno Associated Virus type 2 Antibody (AAV2-Ab) Elisa kit

E01A43800 96T
EUR 700
Description: ELISA

Mouse Adeno Associated Virus type 2 Antibody (AAV2-Ab) ELISA kit

E03A0397-192T 192 tests
EUR 1524
Description: A competitive ELISA for quantitative measurement of Mouse Adeno Associated Virus type 2 Antibody (AAV2-Ab) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Mouse Adeno Associated Virus type 2 Antibody (AAV2-Ab) ELISA kit

E03A0397-48 1 plate of 48 wells
EUR 624
Description: A competitive ELISA for quantitative measurement of Mouse Adeno Associated Virus type 2 Antibody (AAV2-Ab) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Mouse Adeno Associated Virus type 2 Antibody (AAV2-Ab) ELISA kit

E03A0397-96 1 plate of 96 wells
EUR 822
Description: A competitive ELISA for quantitative measurement of Mouse Adeno Associated Virus type 2 Antibody (AAV2-Ab) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Human Adeno Associated Virus type 2 Antibody (AAV2-Ab) ELISA kit

E01A0397-192T 192 tests
EUR 1524
Description: A competitive ELISA for quantitative measurement of Human Adeno Associated Virus type 2 Antibody (AAV2-Ab) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Human Adeno Associated Virus type 2 Antibody (AAV2-Ab) ELISA kit

E01A0397-96 1 plate of 96 wells
EUR 822
Description: A competitive ELISA for quantitative measurement of Human Adeno Associated Virus type 2 Antibody (AAV2-Ab) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Sheep Adeno Associated Virus type 2 Antibody (AAV2-Ab) Elisa kit

E01A96093 96T
EUR 700
Description: ELISA

Mouse Adeno Associated Virus type 2 Antibody (AAV2-Ab) Elisa kit

E01A17621 96T
EUR 700
Description: ELISA

Human Adeno Associated Virus type 2 Antibody (AAV2-Ab) Elisa kit

E01A0116 96T
EUR 700
Description: ELISA

Monkey Adeno Associated Virus type 2 Antibody (AAV2-Ab) ELISA kit

E09A0397-192T 192 tests
EUR 1524
Description: A competitive ELISA for quantitative measurement of Monkey Adeno Associated Virus type 2 Antibody (AAV2-Ab) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Monkey Adeno Associated Virus type 2 Antibody (AAV2-Ab) ELISA kit

E09A0397-48 1 plate of 48 wells
EUR 624
Description: A competitive ELISA for quantitative measurement of Monkey Adeno Associated Virus type 2 Antibody (AAV2-Ab) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Monkey Adeno Associated Virus type 2 Antibody (AAV2-Ab) ELISA kit

E09A0397-96 1 plate of 96 wells
EUR 822
Description: A competitive ELISA for quantitative measurement of Monkey Adeno Associated Virus type 2 Antibody (AAV2-Ab) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Rabbit Adeno Associated Virus type 2 Antibody (AAV2-Ab) ELISA kit

E04A0397-192T 192 tests
EUR 1524
Description: A competitive ELISA for quantitative measurement of Rabbit Adeno Associated Virus type 2 Antibody (AAV2-Ab) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Rabbit Adeno Associated Virus type 2 Antibody (AAV2-Ab) ELISA kit

E04A0397-48 1 plate of 48 wells
EUR 624
Description: A competitive ELISA for quantitative measurement of Rabbit Adeno Associated Virus type 2 Antibody (AAV2-Ab) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Rabbit Adeno Associated Virus type 2 Antibody (AAV2-Ab) ELISA kit

E04A0397-96 1 plate of 96 wells
EUR 822
Description: A competitive ELISA for quantitative measurement of Rabbit Adeno Associated Virus type 2 Antibody (AAV2-Ab) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Bovine Adeno Associated Virus type 2 Antibody (AAV2-Ab) Elisa kit

E01A78664 96T
EUR 700
Description: ELISA

Monkey Adeno Associated Virus type 2 Antibody (AAV2-Ab) Elisa kit

E01A69947 96T
EUR 700
Description: ELISA

Canine Adeno Associated Virus type 2 Antibody (AAV2-Ab) Elisa kit

E01A61235 96T
EUR 700
Description: ELISA

Rabbit Adeno Associated Virus type 2 Antibody (AAV2-Ab) Elisa kit

E01A26368 96T
EUR 700
Description: ELISA

Chicken Adeno Associated Virus type 2 Antibody (AAV2-Ab) Elisa kit

E01A87390 96T
EUR 700
Description: ELISA

Porcine Adeno Associated Virus type 2 Antibody (AAV2-Ab) Elisa kit

E01A52517 96T
EUR 700
Description: ELISA

HSV-1 Virus Control Stock

20-4810020 Single Use, 400 µL, shipped frozen Ask for price
Description: Genetically Engineered BHK Cells

HSV-2 Virus Control Stock

20-4820020 Single Use, 400 µL, shipped frozen Ask for price
Description: Genetically Engineered BHK Cells

Guinea pig Adeno Associated Virus type 2 Antibody (AAV2-Ab) ELISA kit

E05A0397-192T 192 tests
EUR 1524
Description: A competitive ELISA for quantitative measurement of Guinea pig Adeno Associated Virus type 2 Antibody (AAV2-Ab) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Guinea pig Adeno Associated Virus type 2 Antibody (AAV2-Ab) ELISA kit

E05A0397-48 1 plate of 48 wells
EUR 624
Description: A competitive ELISA for quantitative measurement of Guinea pig Adeno Associated Virus type 2 Antibody (AAV2-Ab) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Guinea pig Adeno Associated Virus type 2 Antibody (AAV2-Ab) ELISA kit

E05A0397-96 1 plate of 96 wells
EUR 822
Description: A competitive ELISA for quantitative measurement of Guinea pig Adeno Associated Virus type 2 Antibody (AAV2-Ab) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Guinea Pig Adeno Associated Virus type 2 Antibody (AAV2-Ab) Elisa kit

E01A35082 96T
EUR 700
Description: ELISA

Lenti-III-UBC-GFP Control Virus

LV027 4 x 500 ul
EUR 195

Lenti-III-PGK-GFP Control Virus

LV028 4 x 500 ul
EUR 195

pRedTK-CMV Virus [positive control]

SR10052VA-1 >2 x 10^6 IFUs
EUR 625

pRedZeo-CMV Virus [positive control]

SR10046VA-1 >2 x 10^6 IFUs
EUR 625

Lenti-III-EF1alpha-GFP Control Virus

LV046 4 x 500 ul
EUR 195

Adeno-Associated Virus 2 / AAV2 (VP1 + VP2 + VP3) rabbit polyclonal antibody, Serum

BP5024 250 µl Ask for price

pGreenZeo-CMV Virus [positive control]

SR501VA-1 >2 x 10^6 IFUs
EUR 608

pGreenZeo-mCMV Virus [negative control]

SR500VA-1 >2 x 10^6 IFUs
EUR 608

Adeno-Associated Virus 2 / AAV2 (VP1) mouse monoclonal antibody, clone A1, Purified

BM5013 50 µg Ask for price

Adeno-Associated Virus 2 / AAV2 (VP1 / VP2) mouse monoclonal antibody, clone A69, Purified

BM5014 50 µg Ask for price

Virus-Like Particles (VLPs) isotype control

CSB-MP3838 11453 mg Ask for price

Adeno-Associated Virus 2 / AAV2 (intact particle) mouse monoclonal antibody, clone A20, Biotin

BM5010B 750 µl Ask for price

pCDH-Cuo-RFP-T2A-GFP (positive control virus)

QM350VA-1 >1 x 10^6 IFUs
EUR 573

Adeno-Associated Virus 2 / AAV2 (intact particle) mouse monoclonal antibody, clone A20, Purified

BM5010 50 µg Ask for price

Influenza A virus HA Control/blocking peptide

AB-23091-P 100ug
EUR 196.8

Virus-Like Particle (VLP) Protein Isotype Control

VLP-N5213 30ug
EUR 428
Description: VLP isotype control (VLP-N5213) is expressed from human 293 cells (HEK293).

AAV2 Luciferase

78453 50 µl x 2
EUR 545
Description: Adeno-Associated Virus serotype 2 (AAV2) is the best characterized AAV serotype. Nearly all recombinant AAV serotypes utilize the AAV2 inverted terminal repeats (ITRs). AAV2 requires the expression of Heparan Sulfate Proteoglycan (HSPG) on the surface of host for cells for binding and internalization. Of nearly all the discovered AAV serotypes, AAV2 has the best transduction efficiency in cell culture and is the best tool for in vitro studies._x000D_These AAV particles constitutively express the firefly (Photinus pyralis) luciferase under the control of a CMV promoter.

Vaccinia virus Complement control protein C3 (VACWR025)

1-CSB-YP302389VAI
  • EUR 814.80
  • EUR 402.00
  • EUR 2606.40
  • EUR 1261.20
  • EUR 1730.40
  • EUR 522.00
  • 100ug
  • 10ug
  • 1MG
  • 200ug
  • 500ug
  • 50ug
Description: Recombinant Vaccinia virus Complement control protein C3(VACWR025) expressed in Yeast

Adeno-Associated Virus 2 / AAV2 (Replicase Rep 78, 52) mouse monoclonal antibody, clone 76.3, Purified

BM5011 100 µg Ask for price

pGreenPuro Scramble Hairpin Control - Virus (for shRNAs and miRZips)

MZIP000-VA-1 >1 x 10^6 IFUs
EUR 652

Baboon Anti-Rabies Virus IgG antiserum negative control

600-070-03N 1 ml
EUR 196.8

Baboon Anti-Rabies Virus IgG antiserum positive control

600-070-04P 1 ml
EUR 270

Recombinant Polyoma Virus (KV, Pneumotropic virus) Capsid Protein 1 (VP1) control for Western blot

KVP14-C 100 ul
EUR 343.2

Camelpox virus H3L/p35 protein control for western blot

CPOX11-C 100 ul
EUR 343.2

Zika Virus prM Protein (African) control for Western blot

ZPRM11-C 100 ul
EUR 343.2

NATtrol BK Virus External Run Control, Low (6 X 1 mL)

NATBK-ERCL 6 X 1 mL
EUR 360

Mayaro virus (MAYV) 6K Protein control for Western Blotting

MAYV51-C 100 ug
EUR 343.2

Mayaro virus (MAYV) E3 protein control for Western Blotting

MAYV61-C 100 ul
EUR 343.2

Simian virus 5 (starin W3) P/V Control/blocking peptide

AB-23077-P 100ug
EUR 196.8

Fluorescent Virus-Like Particle (VLP) Protein Isotype Control

VLP-NF2P4 30ug
EUR 428
Description: Fluorescent VLP isotype control (VLP-NF2P4) is expressed from human 293 cells (HEK293).

Adeno-Associated Virus 2 / AAV2 (Replicase Rep 78, 68, 52, 40) mouse monoclonal antibody, clone 259.5, Purified

BM5092 50 µg Ask for price

NATtrol Zika Virus, External Run Control, Low (6 x 1 mL)

NATZIKV-ERCL 6 x 1 mL
EUR 350

Mayaro virus (MAYV) nsP1 protein control for Western Blotting

MAYV41-C 100 ul
EUR 343.2

Purified Nipah virus Glycoprotein control for Western Blotting

NIV11-C 100 ul
EUR 343.2

NATtrol BK Virus External Run Control, Medium (6 X 1 mL)

NATBK-ERCM 6 X 1 mL
EUR 438

Purified Nipah virus Nucleoprotein control for Western Blotting

NIV21-C 100 ul
EUR 270

Adeno-Associated Virus 2 / AAV2 (Replicase Rep 78, 68, 52, 40) mouse monoclonal antibody, clone 226.7, Supernatant

BM5012SU 5 ml Ask for price

Human Anti-Mumps Virus (parotitis) IgG negative control serum

520-100-01N 1 ml
EUR 196.8

Human Anti-Mumps Virus (parotitis) IgG positive control serum

520-100-02P 1 ml
EUR 270

Mouse Anti-Mumps Virus (parotitis) IgG negative control serum

520-130-05N 1 ml
EUR 196.8

Mouse Anti-Mumps Virus (parotitis) IgG positive control serum

520-130-06P 1 ml
EUR 270

Mayaro virus (MAYV) Capsid Protein control for Western Blotting

MAYV31-C 100 ul
EUR 343.2

NATtrol Zika Virus, External Run Control, Medium (6 x 1 mL)

NATZIKV-ERCM 6 x 1 mL
EUR 425

Recombinant Vaccinia virus Complement control protein C3 (VACWR025)

CSB-YP302389VAI 6104 mg Ask for price

Recombinant Vaccinia virus Complement control protein C3(VACWR025)

AP74192 1mg
EUR 3389

Monkey Anti-Mumps Virus (parotitis) IgG negative control serum

520-160-03N 1 ml
EUR 196.8

Monkey Anti-Mumps Virus (parotitis) IgG positive control serum

520-160-04P 1 ml
EUR 270

AAV2 Luciferase-eGFP

78462 50 µl x 2
EUR 545
Description: Adeno-Associated Virus serotype 2 (AAV2) is the best characterized AAV serotype. Nearly all recombinant AAV serotypes utilize the AAV2 inverted terminal repeats (ITRs). AAV2 requires the expression of Heparan Sulfate Proteoglycan (HSPG) on the surface of host cells for binding and internalization. Of nearly all the discovered AAV serotypes, AAV2 has the best transduction efficiency in cell culture and is the best tool for in vitro studies._x000D_These AAV particles constitutively express the firefly (Photinus pyralis) luciferase and eGFP genes connected via a T2A linker, under the control of a CMV promoter. The T2A self-cleaving peptide (derived from Thosea asigna virus 2A) leads to the efficient cleavage of the transcript and expression of luciferase and eGFP as two separate proteins.

Adeno-Associated Virus 2 / AAV2 (Replicase Rep 78, 68, 52, 40) mouse monoclonal antibody, clone 303.9, Aff - Purified

AM09104PU-N 50 µg Ask for price

Cynos Monkey Anti-Rabies Virus IgG antiserum positive control

600-070-06P 1 ml
EUR 270

Bovine Lumpy skin disease virus (LSDV) control for western blot

LSDV11-C 100 ul
EUR 343.2

Rabies Virus Glycoprotein (~58 kda, RVG) control for western blot

RBVGP11-C 100 ul
EUR 343.2

AAV2 Luciferase-mCherry

78471 50 µl x 2
EUR 545
Description: Adeno-Associated Virus serotype 2 (AAV2) is the best characterized AAV serotype. Nearly all recombinant AAV serotypes utilize the AAV2 inverted terminal repeats (ITRs). AAV2 requires the expression of Heparan Sulfate Proteoglycan (HSPG) on the surface of host cells for binding and internalization. Of nearly all the discovered AAV serotypes, AAV2 has the best transduction efficiency in cell culture and is the best tool for in vitro studies._x000D_These AAV particles constitutively express the firefly (Photinus pyralis) luciferase and mCherry genes connected via a T2A linker, under the control of a CMV promoter. The T2A self-cleaving peptide (derived from Thosea asigna virus 2A) leads to the efficient cleavage of the transcript, and expression of luciferase and mCherry as two separate proteins.

saCas9 Nuclease AAV Virus (AAV10)

K217 2 x 250 µl, 1 x 10^9 GC/ml, Titer: 1 x 10^9 GC/ml
EUR 375
Description: This AAV vector expresses the Cas9 orthologue from Staphylococcus Aureus (saCas9). saCas9 is ~1 kb shorter than spCas9, allowing it to be efficiently packaged in AAV Virus. Furthermore, the saCas9 enzyme recognizes a longer PAM sequence than spCas9, and thus has greater editing specificity.AAV has low immunogenicity and broad host range, making it an ideal choice for both in vivo and in vitro applications. Use this saCas9-expressing AAV virus with a target-specific saCas9-compatible sgRNA for highly specific and efficient genome editing.

saCas9 Nuclease AAV Virus (AAV11)

K218 2 x 250 µl, 1 x 10^9 GC/ml, Titer: 1 x 10^9 GC/ml
EUR 375
Description: This AAV vector expresses the Cas9 orthologue from Staphylococcus Aureus (saCas9). saCas9 is ~1 kb shorter than spCas9, allowing it to be efficiently packaged in AAV Virus. Furthermore, the saCas9 enzyme recognizes a longer PAM sequence than spCas9, and thus has greater editing specificity.AAV has low immunogenicity and broad host range, making it an ideal choice for both in vivo and in vitro applications. Use this saCas9-expressing AAV virus with a target-specific saCas9-compatible sgRNA for highly specific and efficient genome editing.

Rhesus Monkey Anti-Rabies Virus IgG antiserum negative control

600-070-01N 1 ml
EUR 196.8

Rhesus Monkey Anti-Rabies Virus IgG antiserum positive control

600-070-02P 1 ml
EUR 270

Camel Anti-Camelpox virus H3L/p35 IgG negative control serum

AE-311170-01N 1 ml
EUR 196.8

Camel Anti-Camelpox virus H3L/p35 IgG positive control serum

AE-311170-02P 1 ml
EUR 270

OPEF01337-1ML - Epstein-Barr Virus (EBV) Negative Control Extract

OPEF01337-1ML 1ml
EUR 174

Control/Blocking peptide for Tobacco Mosaic Virus Movement Protein

TMVMP11-P 100 ug
EUR 196.8

OPEF01337-25ML - Epstein-Barr Virus (EBV) Negative Control Extract

OPEF01337-25ML 25ml
EUR 2901

Monkey (Cynomolgous) Anti-Rabies Virus IgG antiserum negative control

600-070-05N 1 ml
EUR 196.8

saCas9 Nuclease AAV Virus (AAV1)

K208 2 x 250 µl, 1 x 10^9 GC/ml, Titer: 1 x 10^9 GC/ml
EUR 375
Description: This AAV vector expresses the Cas9 orthologue from Staphylococcus Aureus (saCas9). saCas9 is ~1 kb shorter than spCas9, allowing it to be efficiently packaged in AAV Virus. Furthermore, the saCas9 enzyme recognizes a longer PAM sequence than spCas9, and thus has greater editing specificity.AAV has low immunogenicity and broad host range, making it an ideal choice for both in vivo and in vitro applications. Use this saCas9-expressing AAV virus with a target-specific saCas9-compatible sgRNA for highly specific and efficient genome editing.

saCas9 Nuclease AAV Virus (AAV3)

K210 2 x 250 µl, 1 x 10^9 GC/ml, Titer: 1 x 10^9 GC/ml
EUR 375
Description: This AAV vector expresses the Cas9 orthologue from Staphylococcus Aureus (saCas9). saCas9 is ~1 kb shorter than spCas9, allowing it to be efficiently packaged in AAV Virus. Furthermore, the saCas9 enzyme recognizes a longer PAM sequence than spCas9, and thus has greater editing specificity.AAV has low immunogenicity and broad host range, making it an ideal choice for both in vivo and in vitro applications. Use this saCas9-expressing AAV virus with a target-specific saCas9-compatible sgRNA for highly specific and efficient genome editing.

saCas9 Nuclease AAV Virus (AAV4)

K211 2 x 250 µl, 1 x 10^9 GC/ml, Titer: 1 x 10^9 GC/ml
EUR 375
Description: This AAV vector expresses the Cas9 orthologue from Staphylococcus Aureus (saCas9). saCas9 is ~1 kb shorter than spCas9, allowing it to be efficiently packaged in AAV Virus. Furthermore, the saCas9 enzyme recognizes a longer PAM sequence than spCas9, and thus has greater editing specificity.AAV has low immunogenicity and broad host range, making it an ideal choice for both in vivo and in vitro applications. Use this saCas9-expressing AAV virus with a target-specific saCas9-compatible sgRNA for highly specific and efficient genome editing.

saCas9 Nuclease AAV Virus (AAV5)

K212 2 x 250 µl, 1 x 10^9 GC/ml, Titer: 1 x 10^9 GC/ml
EUR 375
Description: This AAV vector expresses the Cas9 orthologue from Staphylococcus Aureus (saCas9). saCas9 is ~1 kb shorter than spCas9, allowing it to be efficiently packaged in AAV Virus. Furthermore, the saCas9 enzyme recognizes a longer PAM sequence than spCas9, and thus has greater editing specificity.AAV has low immunogenicity and broad host range, making it an ideal choice for both in vivo and in vitro applications. Use this saCas9-expressing AAV virus with a target-specific saCas9-compatible sgRNA for highly specific and efficient genome editing.

saCas9 Nuclease AAV Virus (AAV6)

K213 2 x 250 µl, 1 x 10^9 GC/ml, Titer: 1 x 10^9 GC/ml
EUR 375
Description: This AAV vector expresses the Cas9 orthologue from Staphylococcus Aureus (saCas9). saCas9 is ~1 kb shorter than spCas9, allowing it to be efficiently packaged in AAV Virus. Furthermore, the saCas9 enzyme recognizes a longer PAM sequence than spCas9, and thus has greater editing specificity.AAV has low immunogenicity and broad host range, making it an ideal choice for both in vivo and in vitro applications. Use this saCas9-expressing AAV virus with a target-specific saCas9-compatible sgRNA for highly specific and efficient genome editing.

saCas9 Nuclease AAV Virus (AAV7)

K214 2 x 250 µl, 1 x 10^9 GC/ml, Titer: 1 x 10^9 GC/ml
EUR 375
Description: This AAV vector expresses the Cas9 orthologue from Staphylococcus Aureus (saCas9). saCas9 is ~1 kb shorter than spCas9, allowing it to be efficiently packaged in AAV Virus. Furthermore, the saCas9 enzyme recognizes a longer PAM sequence than spCas9, and thus has greater editing specificity.AAV has low immunogenicity and broad host range, making it an ideal choice for both in vivo and in vitro applications. Use this saCas9-expressing AAV virus with a target-specific saCas9-compatible sgRNA for highly specific and efficient genome editing.

saCas9 Nuclease AAV Virus (AAV8)

K215 2 x 250 µl, 1 x 10^9 GC/ml, Titer: 1 x 10^9 GC/ml
EUR 375
Description: This AAV vector expresses the Cas9 orthologue from Staphylococcus Aureus (saCas9). saCas9 is ~1 kb shorter than spCas9, allowing it to be efficiently packaged in AAV Virus. Furthermore, the saCas9 enzyme recognizes a longer PAM sequence than spCas9, and thus has greater editing specificity.AAV has low immunogenicity and broad host range, making it an ideal choice for both in vivo and in vitro applications. Use this saCas9-expressing AAV virus with a target-specific saCas9-compatible sgRNA for highly specific and efficient genome editing.

saCas9 Nuclease AAV Virus (AAV9)

K216 2 x 250 µl, 1 x 10^9 GC/ml, Titer: 1 x 10^9 GC/ml
EUR 375
Description: This AAV vector expresses the Cas9 orthologue from Staphylococcus Aureus (saCas9). saCas9 is ~1 kb shorter than spCas9, allowing it to be efficiently packaged in AAV Virus. Furthermore, the saCas9 enzyme recognizes a longer PAM sequence than spCas9, and thus has greater editing specificity.AAV has low immunogenicity and broad host range, making it an ideal choice for both in vivo and in vitro applications. Use this saCas9-expressing AAV virus with a target-specific saCas9-compatible sgRNA for highly specific and efficient genome editing.
The 120 included articles yielded ideas associated to contextual (knowledge supply, custodian, and consumer) and technical (interoperability) elements throughout the info life cycle. Contextual DQ subcategories included relevance, usability, accessibility, timeliness, and belief. Well-tested computable DQ indicators and evaluation instruments have been additionally discovered.  A DQ evaluation framework that covers intrinsic, technical, and contextual classes throughout the info life cycle permits evaluation and administration of RWD repositories to make sure health

Protocol for the development of a repository of individual participant data from randomised controlled trials conducted in adult care homes (the Virtual International Care Homes Trials Archive (VICHTA))

Protocol for the development of a repository of individual participant data from randomised controlled trials conducted in adult care homes (the Virtual International Care Homes Trials Archive (VICHTA))
Approximately 418,000 folks dwell in care homes in the UK, but accessible, sturdy data on care dwelling populations and organisation are missing. This hampers our means to plan, allocate assets or stop threat. Large randomised controlled trials (RCTs) conducted in care homes provide a potential resolution. The worth of detailed data on residents’ demographics, outcomes and contextual info captured in RCTs has but to be absolutely realised. Irrespective of the intervention examined, a lot of the trial data collected overlaps in phrases of structured assessments and descriptive info.
Given the time and prices required to prospectively accumulate data in these populations, pooling anonymised RCT data into a structured repository presents profit; secondary analyses of pooled RCT data can enhance understanding of this under-researched inhabitants and improve the future trial design. This protocol describes the creation of a project-specific repository of individual participant data (IPD) from trials conducted in care homes and subsequent enlargement into a legacy dataset for wider use, to deal with the want for correct, high-quality IPD on this susceptible inhabitants.
Informed by scoping of related literature, the principal investigators of RCTs conducted in adult care homes in the UK since 2010 will probably be invited to contribute trial IPD. Contributing trialists will type a Steering Committee who will oversee data sharing and stay gatekeepers of their very own trial’s data. IPD will probably be cleaned and standardised in session with the Steering Committee for accuracy. Planned analyses embrace a comparability of pooled IPD with level estimates from administrative sources, to evaluate generalisability of RCT data to the wider care dwelling inhabitants.
We may even establish key resident traits and outcomes from inside the trial repository, which is able to inform the development of a nationwide minimal dataset for care homes. Following challenge completion, administration will migrate to the Virtual Trials Archives, forming a legacy dataset which will probably be expanded to incorporate worldwide RCTs, and will probably be accessible to the wider analysis neighborhood for analyses. Analysis of pooled IPD has the potential to tell and direct future follow, analysis and coverage at low value, enhancing the worth of current data and lowering analysis waste. We intention to create a everlasting archive for care dwelling trial data and welcome the contribution of rising trial datasets.

OGP: A Repository of Experimentally Characterized O-Glycoproteins to Facilitate Studies on O-Glycosylation

Numerous research on most cancers, biopharmaceuticals, and medical trials have necessitated complete and exact evaluation of protein O-glycosylation. However, the lack of up to date and handy databases deters the storage of and reference to rising O-glycoprotein data. To resolve this difficulty, an O-glycoprotein repository named OGP was established in this work. It was constructed with a assortment of O-glycoprotein data from completely different sources. OGP accommodates 9354 O-glycosylation websites and 11,633 site-specific O-glycans mapping to 2133 O-glycoproteins, and it’s the largest O-glycoprotein repository to date. Based on the recorded O-glycosylation websites, an O-glycosylation web site prediction instrument was developed.

The first model of OGP repository and the web site enable customers to acquire numerous O-glycoprotein-related info, equivalent to protein accession numbers, O-glycosylation websites, glycopeptide sequences, site-specific glycan constructions, experimental strategies, and potential O-glycosylation websites. To tackle the challenges posed by large-scale development, validation, and adoption of synthetic intelligence (AI) in pathology, now we have constituted a consortium of teachers, small enterprises, and pharmaceutical corporations and proposed the BIGPICTURE challenge to the Innovative Medicines Initiative.

Our imaginative and prescient is to change into the catalyst in the digital transformation of pathology by creating the first European, ethically compliant, and quality-controlled entire slide imaging platform, in which each large-scale data and AI algorithms will exist. Our mission is to develop this platform in a sustainable and inclusive means, by connecting the neighborhood of pathologists, researchers, AI builders, sufferers, and trade events primarily based on creating worth and reciprocity in use primarily based on a neighborhood mannequin as the mechanism for making certain sustainability of the platform.

Protocol for the development of a repository of individual participant data from randomised controlled trials conducted in adult care homes (the Virtual International Care Homes Trials Archive (VICHTA))

Missense3D-DB net catalogue: an atom-based evaluation and repository of 4M human protein-coding genetic variants

The interpretation of human genetic variation is one of the biggest challenges of fashionable genetics. New approaches are urgently wanted to prioritize variants, particularly these which might be uncommon or lack a definitive medical interpretation. We examined 10,136,597 human missense genetic variants from GnomAD, ClinVar and UniProt. We had been capable of carry out large-scale atom-based mapping and phenotype interpretation of 3,960,015 of these variants onto 18,874 experimental and 84,818 in home predicted three-dimensional coordinates of the human proteome.

We show that 14% of amino acid substitutions from the GnomAD database that could possibly be structurally analysed are predicted to have an effect on protein construction (n = 568,548, of which 566,439 uncommon or extraordinarily uncommon) and will, subsequently, have a but unknown disease-causing impact. Moreover, an OGP-based web site is already accessible (http://www.oglyp.org/). The web site contains 4 specifically designed and user-friendly modules: statistical evaluation, database search, web site prediction, and data submission.

Mouse IgG3 Isotype Control (FITC)

abx405036-100tests 100 tests
EUR 510

Mouse IgG3 Isotype Control (PerCP)

abx200591-100ug 100 ug
EUR 878.4

Mouse IgG3 Isotype Control Purified

11-459-C025 0.025 mg
EUR 105.6

Mouse IgG3 Isotype Control Purified

11-459-C100 0.1 mg
EUR 163.2

Mouse IgG3 isotype control, purified

20102-104 100 ug
EUR 169.2

PE mouse IgG3, κ Isotype Control

E16FMCP005K-025U 25 μg
EUR 411.67
Description: Available in various conjugation types.

FITC mouse IgG3, κ Isotype Control

E16FMCF005K-050U 50 μg
EUR 325
Description: Available in various conjugation types.

Mouse IgG3 Isotype Control (OC-515)

abx200593-100ug 100 ug
EUR 727.2

Mouse IgG3 Isotype Control (CF-Blue)

abx200592-100ug 100 ug
EUR 577.2

Biotin mouse IgG3, κ Isotype Control

E16FMCB005K-050U 50 μg
EUR 260
Description: Available in various conjugation types.

Purified mouse IgG3, κ Isotype Control

E16FMCK005K-050U 50 μg
EUR 411.67
Description: Available in various conjugation types.

Mouse IgG3-PE conjugate (isotype control)

20102-104-PE 50 Tests
EUR 242.4

Mouse IgG3-HRP conjugate (isotype control)

20102-104-HP 50 Tests
EUR 196.8

Mouse IgG3-FITC conjugate (isotype control)

20102-104-F 50 tests
EUR 196.8

NE Purified mouse IgG3, κ Isotype Control

E16FMCY005K-500U 500 μg
EUR 780
Description: Available in various conjugation types.

Mouse IgG3-Biotin conjugate (isotype control)

20102-104-B 50 Tests
EUR 196.8

Mouse IgG3 Isotype control (purified) validated fo

NG908 7 ml
EUR 245
Description: Mouse IgG3 Isotype control (purified) validated for IHC; Ready-To-Use

Mouse IgG3 Isotype control (purified) validated fo

NG908C 1 ml
EUR 285
Description: Mouse IgG3 Isotype control (purified) validated for IHC; Concentrate

Mouse IgG3-PE-Cy5 conjugate (isotype control)

20102-104-PC5 50 Tests
EUR 270

Alexa Fluor® 488 mouse IgG3, κ Isotype Control

E16FMCG005K-100U 100 μg
EUR 845
Description: Available in various conjugation types.

Alexa Fluor® 647 mouse IgG3, κ Isotype Control

E16FMCK005K-025U 25 μg
EUR 173.33
Description: Available in various conjugation types.

Mouse IgG3 Isotype Control DyLight® 488

L4-459-C100 0.1 mg
EUR 255.6

Mouse IgG3 Isotype Control DyLight® 650

L6-459-C100 0.1 mg
EUR 255.6

OPRA03551-1MG - Mouse IgG3 Kappa (κ) isotype Control

OPRA03551-1MG 1mg
EUR 249

Mouse IgG3 Kappa Isotype Control Monoclonal Clone A1123 PE

IMSIGG3KICA1123CPE100UG each
EUR 150
Description: Mouse IgG3 Kappa Isotype Control Monoclonal Clone A1123 PE

Mouse IgG3 Kappa Isotype Control Monoclonal Clone A1123 PE

IMSIGG3KICA1123CPE25UG each
EUR 55
Description: Mouse IgG3 Kappa Isotype Control Monoclonal Clone A1123 PE

Mouse IgG3 Kappa Isotype Control Monoclonal Clone A1123 APC

IMSIGG3KICA1123CAPC100UG each
EUR 150
Description: Mouse IgG3 Kappa Isotype Control Monoclonal Clone A1123 APC

Mouse IgG3 Kappa Isotype Control Monoclonal Clone A1123 APC

IMSIGG3KICA1123CAPC25UG each
EUR 55
Description: Mouse IgG3 Kappa Isotype Control Monoclonal Clone A1123 APC

Mouse IgG3 Kappa Isotype Control Monoclonal Clone A1123 FITC

IMSIGG3KICA1123CFITC100UG each
EUR 150
Description: Mouse IgG3 Kappa Isotype Control Monoclonal Clone A1123 FITC

Mouse IgG3 Kappa Isotype Control Monoclonal Clone A1123 FITC

IMSIGG3KICA1123CFITC25UG each
EUR 55
Description: Mouse IgG3 Kappa Isotype Control Monoclonal Clone A1123 FITC

Mouse IgG3 Kappa Isotype Control Monoclonal Clone A1123 AF488

IMSIGG3KICA1123CAF488100UG each
EUR 150
Description: Mouse IgG3 Kappa Isotype Control Monoclonal Clone A1123 AF488

Mouse IgG3 Kappa Isotype Control Monoclonal Clone A1123 AF488

IMSIGG3KICA1123CAF48825UG each
EUR 55
Description: Mouse IgG3 Kappa Isotype Control Monoclonal Clone A1123 AF488

Mouse IgG3 Kappa Isotype Control Monoclonal Clone A1123 AF647

IMSIGG3KICA1123CAF647100UG each
EUR 150
Description: Mouse IgG3 Kappa Isotype Control Monoclonal Clone A1123 AF647

Mouse IgG3 Kappa Isotype Control Monoclonal Clone A1123 AF647

IMSIGG3KICA1123CAF64725UG each
EUR 55
Description: Mouse IgG3 Kappa Isotype Control Monoclonal Clone A1123 AF647

Mouse IgG3 Kappa Isotype Control Monoclonal Clone A1123 ER780

IMSIGG3KICA1123CER780100UG each
EUR 150
Description: Mouse IgG3 Kappa Isotype Control Monoclonal Clone A1123 ER780

Mouse IgG3 Kappa Isotype Control Monoclonal Clone A1123 ER780

IMSIGG3KICA1123CER78025UG each
EUR 55
Description: Mouse IgG3 Kappa Isotype Control Monoclonal Clone A1123 ER780

Mouse IgG3 Kappa Isotype Control Monoclonal Clone A1123 EV450

IMSIGG3KICA1123CEV450100UG each
EUR 150
Description: Mouse IgG3 Kappa Isotype Control Monoclonal Clone A1123 EV450

Mouse IgG3 Kappa Isotype Control Monoclonal Clone A1123 EV450

IMSIGG3KICA1123CEV45025UG each
EUR 55
Description: Mouse IgG3 Kappa Isotype Control Monoclonal Clone A1123 EV450

Mouse IgG3 Kappa Isotype Control Monoclonal Clone A1123 Biotin

IMSIGG3KICA1123CBL100UG each
EUR 150
Description: Mouse IgG3 Kappa Isotype Control Monoclonal Clone A1123 Biotin

Mouse IgG3 Kappa Isotype Control Monoclonal Clone A1123 Biotin

IMSIGG3KICA1123CBL25UG each
EUR 55
Description: Mouse IgG3 Kappa Isotype Control Monoclonal Clone A1123 Biotin

Mouse IgG1 Isotype Control

abx139001-01mg 0.1 mg
EUR 376.8

Mouse IgG1 Isotype Control

abx139002-01mg 0.1 mg
EUR 376.8

Mouse IgG1 Isotype Control

abx139008-01mg 0.1 mg
EUR 376.8

Mouse IgG1 Isotype Control

abx200564-100ug 100 ug
EUR 376.8

Mouse IgG1 Isotype Control

abx405007-01mg 0.1 mg
EUR 493.2

Mouse IgG1 Isotype Control

abx405009-05mg 0.5 mg
EUR 828

Mouse IgG1 Isotype Control

abx405012-1mg 1 mg
EUR 1296

Mouse IgG1 Isotype Control

abx405064-100tests 100 tests
EUR 493.2

Mouse IgG1 Isotype Control

abx405067-05mg 0.5 mg
EUR 994.8

Mouse IgG1 Isotype Control

E2790003 100ul
EUR 225
Description: Available in various conjugation types.

Mouse IgG1 Isotype Control

ICIGG1PU-01MG 100 tests
EUR 126.5

Mouse IgG2a Isotype Control

abx139004-01mg 0.1 mg
EUR 376.8

Mouse IgG2a Isotype Control

abx139005-01mg 0.1 mg
EUR 376.8

Mouse IgG2b Isotype Control

abx139006-01mg 0.1 mg
EUR 376.8

Mouse IgG2a Isotype Control

abx139009-01mg 0.1 mg
EUR 376.8

Mouse IgG2b Isotype Control

abx139011-01mg 0.1 mg
EUR 376.8

Mouse IgG2a Isotype Control

abx200572-100ug 100 ug
EUR 376.8

Mouse IgG2b Isotype Control

abx200580-100ug 100 ug
EUR 376.8

Mouse IgG2a Isotype Control

abx405013-100tests 100 tests
EUR 493.2

Mouse IgG2a Isotype Control

abx405015-05mg 0.5 mg
EUR 828

Mouse IgG2a Isotype Control

abx405018-1mg 1 mg
EUR 1328.4

Mouse IgG2b Isotype Control

abx405056-100tests 100 tests
EUR 493.2

Mouse IgG2b Isotype Control

abx405061-1mg 1 mg
EUR 1296

Mouse IgG2a Isotype Control

abx405070-100tests 100 tests
EUR 493.2

Mouse IgG2a Isotype Control

abx405073-05mg 0.5 mg
EUR 994.8

Mouse IgG2a Isotype Control

10R-I117d 1 mg
EUR 663.6
Description: Purified Mouse IgG2a Isotype Control

Mouse IgG2a Isotype Control

E2790004 100ul
EUR 225
Description: Available in various conjugation types.

Mouse IgG2b Isotype Control

E2790005 100ul
EUR 225
Description: Available in various conjugation types.

Mouse IgG Isotype Control

IC002-100ul 100ul
EUR 146.4

Mouse IgG3 Kappa Isotype Control Monoclonal Clone A1123 PE/Cyanine5

IMSIGG3KICA1123CPECY5100UG each
EUR 150
Description: Mouse IgG3 Kappa Isotype Control Monoclonal Clone A1123 PE/Cyanine5

Mouse IgG3 Kappa Isotype Control Monoclonal Clone A1123 PE/Cyanine5

IMSIGG3KICA1123CPECY525UG each
EUR 55
Description: Mouse IgG3 Kappa Isotype Control Monoclonal Clone A1123 PE/Cyanine5

Mouse IgG1 Isotype Control (PE)

abx139025-01mg 0.1 mg
EUR 510

Mouse IgG1 Isotype Control (PE)

abx200566-50ug 50 ug
EUR 510

Mouse IgG1 Isotype Control PE

1P-632-C025 0.025 mg
EUR 146.4

Mouse IgG1 Isotype Control PE

1P-632-C100 0.1 mg
EUR 244.8

Mouse IgG1 Isotype Control (PE)

E2790238 100ul
EUR 225
Description: Available in various conjugation types.

PE mouse IgG1 Isotype Control

E16FMCP001-050 50 tests
EUR 235.2
Description: Available in various conjugation types.

PE mouse IgG1 Isotype Control

E16FMCP001-100 100 Tests
EUR 336
Description: Available in various conjugation types.

Mouse IgG3 Kappa Isotype Control Monoclonal Clone A1123 PerCP/Cyanine5.5

IMSIGG3KICA1123CPERCPCY55100UG each
EUR 150
Description: Mouse IgG3 Kappa Isotype Control Monoclonal Clone A1123 PerCP/Cyanine5.5

Mouse IgG3 Kappa Isotype Control Monoclonal Clone A1123 PerCP/Cyanine5.5

IMSIGG3KICA1123CPERCPCY5525UG each
EUR 55
Description: Mouse IgG3 Kappa Isotype Control Monoclonal Clone A1123 PerCP/Cyanine5.5

Mouse IgG1 Isotype Control (APC)

abx139022-01mg 0.1 mg
EUR 510

Mouse IgG1 Isotype Control (APC)

abx200567-50ug 50 ug
EUR 510

Mouse IgG1 Isotype Control (RPE)

abx405011-100tests 100 tests
EUR 760.8

Mouse IgG1 Isotype Control (APC)

abx405065-100tests 100 tests
EUR 493.2

Mouse IgG1 Isotype Control (RPE)

abx405069-100tests 100 tests
EUR 560.4

Mouse IgG1 Isotype Control APC

1A-632-C025 0.025 mg
EUR 146.4

Mouse IgG1 Isotype Control APC

1A-632-C100 0.1 mg
EUR 244.8

Mouse IgG1 Isotype Control (APC)

E2790221 100ul
EUR 225
Description: Available in various conjugation types.

APC mouse IgG1 Isotype Control

E16FMCA001-050 50 tests
EUR 268.67
Description: Available in various conjugation types.

APC mouse IgG1 Isotype Control

E16FMCA001-100 100 Tests
EUR 403.2
Description: Available in various conjugation types.

Mouse IgG1 Isotype Control (FITC)

abx139024-01mg 0.1 mg
EUR 460.8

Mouse IgG1 Isotype Control (FITC)

abx200565-100ug 100 ug
EUR 376.8

Mouse IgG1 Isotype Control (FITC)

abx405010-01mg 0.1 mg
EUR 610.8

Mouse IgG1 Isotype Control (FITC)

abx405068-100tests 100 tests
EUR 493.2

Mouse IgG1 Isotype Control FITC

1F-632-C025 0.025 mg
EUR 129.6

Mouse IgG1 Isotype Control FITC

1F-632-C100 0.1 mg
EUR 212.4

Mouse IgG1 Isotype Control (FITC)

E2790234 100ul
EUR 225
Description: Available in various conjugation types.

FITC mouse IgG1 Isotype Control

E16FMCF001-050 50 tests
EUR 168
Description: Available in various conjugation types.

FITC mouse IgG1 Isotype Control

E16FMCF001-100 100 Tests
EUR 268.8
Description: Available in various conjugation types.

Mouse IgG1 Isotype Control (PerCP)

abx139026-01mg 0.1 mg
EUR 560.4

Mouse IgG1 Isotype Control (PerCP)

abx200568-100ug 100 ug
EUR 510

Mouse IgG1 Isotype Control PerCP

PC-632-C025 0.025 mg
EUR 163.2

Mouse IgG1 Isotype Control PerCP

PC-632-C100 0.1 mg
EUR 277.2

Mouse IgG2a Isotype Control (PE)

abx139015-01mg 0.1 mg
EUR 510

Mouse IgG2b Isotype Control (PE)

abx139020-01mg 0.1 mg
EUR 510

Mouse IgG2a Isotype Control (PE)

abx200574-50ug 50 ug
EUR 510

Mouse IgG2b Isotype Control (PE)

abx200582-50ug 50 ug
EUR 510

Mouse IgG2b Isotype Control PE

1P-692-C025 0.025 mg
EUR 146.4

Mouse IgG2b Isotype Control PE

1P-692-C100 0.1 mg
EUR 244.8

Mouse IgG2a Isotype Control PE

1P-724-C025 0.025 mg
EUR 146.4

Mouse IgG2a Isotype Control PE

1P-724-C100 0.1 mg
EUR 244.8

Mouse IgG2a Isotype Control (PE)

E2790239 100ul
EUR 225
Description: Available in various conjugation types.

Mouse IgG2b Isotype Control (PE)

E2790240 100ul
EUR 225
Description: Available in various conjugation types.

PE mouse IgG2a Isotype Control

E16FMCP002-050 50 tests
EUR 235.2
Description: Available in various conjugation types.

PE mouse IgG2a Isotype Control

E16FMCP002-100 100 Tests
EUR 336
Description: Available in various conjugation types.

PE mouse IgG2b Isotype Control

E16FMCP003-050 50 tests
EUR 235.2
Description: Available in various conjugation types.

PE mouse IgG2b Isotype Control

E16FMCP003-100 100 Tests
EUR 336
Description: Available in various conjugation types.

Mouse IgG1 Isotype Control (Biotin)

abx139023-01mg 0.1 mg
EUR 460.8

Mouse IgG1 Isotype Control (Biotin)

abx405008-01mg 0.1 mg
EUR 610.8

Mouse IgG1 Isotype Control (Biotin)

abx405066-100tests 100 tests
EUR 493.2

Mouse IgG1 Isotype Control Biotin

1B-632-C025 0.025 mg
EUR 129.6

Mouse IgG1 Isotype Control Biotin

1B-632-C100 0.1 mg
EUR 212.4

Biotin mouse IgG1 Isotype Control

E16FMCB001-050 50 tests
EUR 168
Description: Available in various conjugation types.

Biotin mouse IgG1 Isotype Control

E16FMCB001-100 100 Tests
EUR 268.8
Description: Available in various conjugation types.

Biotin mouse IgG1 Isotype Control

E16FMCB001-100U 100 μg
EUR 268.8
Description: Available in various conjugation types.

Biotin mouse IgG1 Isotype Control

E16FMCB001-500U 500 μg
EUR 739.2
Description: Available in various conjugation types.

Mouse IgG2a Isotype Control (APC)

abx139012-01mg 0.1 mg
EUR 510

Mouse IgG2b Isotype Control (APC)

abx139017-01mg 0.1 mg
EUR 510

Mouse IgG2a Isotype Control (APC)

abx200575-50ug 50 ug
EUR 510

Mouse IgG2b Isotype Control (APC)

abx200583-50ug 50 ug
EUR 510

Mouse IgG2a Isotype Control (RPE)

abx405017-100tests 100 tests
EUR 760.8

Mouse IgG2b Isotype Control (APC)

abx405057-100tests 100 tests
EUR 577.2

the similar is true for 19.0% (n = 6266) of variants of unknown medical significance or conflicting interpretation reported in the ClinVar database. The outcomes of the structural evaluation can be found in the devoted net catalogue Missense3D-DB. For every of the four M variants, the outcomes of the structural evaluation are introduced in a pleasant concise format that may be included in medical genetic stories. An in depth report of the structural evaluation can also be accessible for the non-experts in structural biology. Population frequency and predictions from SIFT and PolyPhen are included for a extra complete variant interpretation. This is the first large-scale atom-based structural interpretation of human genetic variation and presents geneticists and the biomedical neighborhood a new method to genetic variant interpretation.

A content-based dataset recommendation system for researchers-a case study on Gene Expression Omnibus (GEO) repository

A content-based dataset recommendation system for researchers-a case study on Gene Expression Omnibus (GEO) repository

It is a rising development amongst researchers to make their knowledge publicly obtainable for experimental reproducibility and knowledge reusability. Sharing knowledge with fellow researchers helps in growing the visibility of the work. On the opposite hand, there are researchers who’re inhibited by the shortage of knowledge sources. To overcome this problem, many repositories and data bases have been established to this point to ease knowledge sharing. Further, prior to now 20 years, there was an exponential enhance within the variety of datasets added to those dataset repositories.

However, most of those repositories are domain-specific, and none of them can advocate datasets to researchers/customers. Naturally, it’s difficult for a researcher to maintain monitor of all of the related repositories for potential use. Thus, a dataset recommender system that recommends datasets to a researcher primarily based on earlier publications can improve their productiveness and expedite additional analysis. The potential to focus onto subnetworks, a number of visualizations and simulation choices will allow the AMD analysis neighborhood to computationally mannequin subnetworks or to check experimentally new hypotheses arising from connectivities in the AMD pathway map.

This work adopts an info retrieval (IR) paradigm for dataset recommendation. We hypothesize that two elementary variations exist between dataset recommendation and PubMed-style biomedical IR past the corpus. First, as an alternative of key phrases, the question is the researcher, embodied by his or her publications. Second, to filter the related datasets from non-relevant ones, researchers are higher represented by a set of pursuits, versus your entire physique of their analysis. This second strategy is applied utilizing a non-parametric clustering method.

These clusters are used to advocate datasets for every researcher utilizing the cosine similarity between the vector representations of publication clusters and datasets. The most normalized discounted cumulative acquire at 10 (NDCG@10), precision at 10 (p@10) partial and p@10 strict of 0.89, 0.78 and 0.61, respectively, have been obtained utilizing the proposed methodology after handbook analysis by 5 researchers. As per one of the best of our data, that is the primary study of its variety on content-based dataset recommendation.

Cancer PRSweb: An Online Repository with Polygenic Risk Scores for Major Cancer Traits and Their Evaluation in Two Independent Biobanks

To facilitate scientific collaboration on polygenic threat scores (PRSs) analysis, we created an intensive PRS on-line repository for 35 frequent most cancers traits integrating freely obtainable genome-wide affiliation research (GWASs) abstract statistics from three sources: printed GWASs, the NHGRI-EBI GWAS Catalog, and UK Biobank-based GWASs. Our framework condenses these abstract statistics into PRSs utilizing varied approaches comparable to linkage disequilibrium pruning/p worth thresholding (mounted or data-adaptively optimized thresholds) and penalized, genome-wide impact dimension weighting.
We evaluated the PRSs in two biobanks: the Michigan Genomics Initiative (MGI), a longitudinal biorepository effort at Michigan Medicine, and the population-based UK Biobank (UKB). For every PRS assemble, we offer measures on predictive efficiency and discrimination. Besides PRS analysis, the Cancer-PRSweb platform options assemble downloads and phenome-wide PRS affiliation study outcomes (PRS-PheWAS) for predictive PRSs. We count on this built-in platform to speed up PRS-related most cancers analysis.
This multicenter, double-blind, randomized, placebo-controlled study enrolled sufferers ≥ 18 years with lively SLE and reasonable to extreme rash and/or arthritis regardless of steady glucocorticoid doses (7.5-30 mg/day prednisone equal) and antimalarials for ≥ Four weeks and/or immunosuppressants for ≥ eight weeks earlier than screening. Stable glucocorticoid doses have been required by way of week 16 with optionally available taper from weeks 16 to 24.
Patients have been randomized (1:1) to 80 U RCI subcutaneously or placebo each different day to week 4, then twice weekly to week 24. Endpoints included the proportion of SLE Responder Index (SRI)-Four responders at week 16; modifications from baseline to week 16 in 28 Swollen Joint Count/Tender Joint Count (28 SJC/TJC) and Cutaneous Lupus Erythematosus Disease Area and Severity Index (CLASI)-Activity rating; and modifications from baseline to week 24 in inflammatory cytokines. Safety was assessed by antagonistic occasions.
A content-based dataset recommendation system for researchers-a case study on Gene Expression Omnibus (GEO) repository

Advancing COVID-19 differentiation with a sturdy preprocessing and integration of multi-institutional open-repository laptop tomography datasets for deep studying evaluation

The coronavirus pandemic and its unprecedented penalties globally has spurred the curiosity of the synthetic intelligence analysis neighborhood. A plethora of printed research have investigated the position of imaging comparable to chest X-rays and laptop tomography in coronavirus illness 2019 (COVID-19) automated analysis. Οpen repositories of medical imaging knowledge can play a big position by selling cooperation amongst institutes in a world-wide scale. However, they might induce limitations associated to variable knowledge high quality and intrinsic variations because of the huge number of scanner distributors and imaging parameters.

In this study, a state-of-the-art customized U-Net mannequin is offered with a cube similarity coefficient efficiency of 99.6% together with a switch studying VGG-19 primarily based mannequin for COVID-19 versus pneumonia differentiation exhibiting an space underneath curve of 96.1%. The above was considerably improved over the baseline mannequin skilled with no segmentation in chosen tomographic slices of the identical dataset. The offered study highlights the significance of a sturdy preprocessing protocol for picture evaluation inside a heterogeneous imaging dataset and assesses the potential diagnostic worth of the offered COVID-19 mannequin by evaluating its efficiency to the state-of-the-art. Health-related knowledge is saved in various repositories which can be managed and managed by completely different entities.

Chicken IgG-FITC conjugate (isotype control, non-immune), purified

20010-1-F 0.5 mg
EUR 270

Chicken IgG-Biotin conjugate (isotype control, non-immune), purified

20010-1-B 0.5 mg
EUR 270

Chicken IgM-Biotin conjugate (isotype control, non-immune) purified

20010-2-1-b 0.1 mg
EUR 270

Chicken IgG-Fc-HRP conjugate (isotype control, non-immune), purified

20010-3-HP 0.1 mg
EUR 270

Chicken IgG-Fc-FITC conjugate (isotype control, non-immune), purified

20010-3-F 0.1 mg
EUR 270

Chicken IgG-Fc-Biotin conjugate (isotype control, non-immune), purified

20010-3-B 0.1 mg
EUR 270

Rat IgG-PE conjugate (isotype control) (Isotype control)

20005-PE 25 tests
EUR 242.4

Rat IgG-HRP conjugate (isotype control) (Isotype control)

20005-HP 100 ug
EUR 196.8

Rat IgG-FITC conjugate (isotype control) (Isotype control)

20005-F 100 ug
EUR 196.8

Rat IgG-Biotin conjugate (isotype control) (Isotype control)

20005-B 100 ug
EUR 196.8

Rabbit Isotype Control

abx200646-100ug 100 ug
EUR 393.6

Rabbit Isotype Control

IMN-001 100 µg
EUR 239.4

Rat IgG Isotype Control

31-AR15 10 mg
EUR 264
Description: Purified Rat IgG Isotype Control

Rat IgM Isotype Control

RIGMA-100 100 µg
EUR 846.24

Rat IgM Isotype Control

RIGMB-200 200 µg
EUR 933.6

Rat IgM Isotype Control

RIGMB-50 50 µg
EUR 304.61

Rat IgM Isotype Control

RIGMF-200 200 µg
EUR 933.6

Rat IgM Isotype Control

RIGMF-50 50 µg
EUR 304.61

Rat IgM Isotype Control

RIGMPE-100 100 µg
EUR 549.22

Rat IgM Isotype Control

RIGMPE-25 25 µg
EUR 287.14

Rat IgM Isotype Control

RIGMPP5.5-25 25 µg
EUR 426.91

Rat IgM Isotype Control

RIGMPU-50 50 µg
EUR 217.25

Rat IgM Isotype Control

RIGMPU-500 500 µg
EUR 479.33

Rat IgG1 Isotype Control

abx405020-05mg 0.5 mg
EUR 460.8

Rat IgG1 Isotype Control

abx405039-05mg 0.5 mg
EUR 460.8

Rat IgG1 Isotype Control

20-abx405041
  • EUR 360.00
  • EUR 526.80
  • 0.1 mg
  • 1 mg

Rat IgG1 Isotype Control

RIGG1A-100 100 µg
EUR 654.05

Rat IgG1 Isotype Control

RIGG1A-25 25 µg
EUR 322.08

Rat IgG1 Isotype Control

RIGG1F-50 50 µg
EUR 357.02

Rat IgG1 Isotype Control

RIGG1F-500 500 µg
EUR 1055.9

Rat IgG1 Isotype Control

RIGG1PE-100 100 µg
EUR 636.58

Rat IgG1 Isotype Control

RIGG1PE-25 25 µg
EUR 304.61

Rat IgG1 Isotype Control

RIGG1PP5.5-100 100 µg
EUR 706.46

Rat IgG1 Isotype Control

RIGG1PP5.5-25 25 µg
EUR 322.08

Rat IgG1 Isotype Control

RIGG1PU-50 50 µg
EUR 217.25

Rat IgG1 Isotype Control

RIGG1PU-500 500 µg
EUR 479.33

Mouse IgM Isotype Control

abx139003-01mg 0.1 mg
EUR 376.8

Mouse IgM Isotype Control

abx200594-100ug 100 ug
EUR 376.8

Rat IgG2a Isotype Control

abx200644-500ug 500 ug
EUR 577.2

Rabbit Isotype Control (PE)

abx200648-100test 100 test
EUR 393.6

Rat IgG2a Isotype Control

abx405022-1ml 1 ml
EUR 360

Rat IgG2a Isotype Control

abx405024-05mg 0.5 mg
EUR 460.8

Rat IgG2a Isotype Control

abx405027-1mg 1 mg
EUR 678

Rat IgG2c Isotype Control

abx405034-025mg 0.25 mg
EUR 644.4

Rat IgG2a Isotype Control

abx405045-05mg 0.5 mg
EUR 460.8

Rat IgG2a Isotype Control

20-abx405047
  • EUR 360.00
  • EUR 526.80
  • 0.1 mg
  • 1 mg

Rat IgG2b Isotype Control

abx405051-05mg 0.5 mg
EUR 460.8

Rat IgG2b Isotype Control

20-abx405053
  • EUR 360.00
  • EUR 526.80
  • 0.1 mg
  • 1 mg

Mouse IgM Isotype Control

abx405062-100tests 100 tests
EUR 493.2

Rat IgG2a Isotype Control

11-168-C025 0.025 mg
EUR 104.4

Rat IgG2b Isotype Control

11-169-C025 0.025 mg
EUR 104.4

Mouse IgM Isotype Control

abx020500-02mg 0.2 mg
EUR 526.8

Rat IgG2b Isotype Control

31R-IC001 500 ug
EUR 289.2
Description: Purified Rat IgG2b Isotype Control

Mouse IgG Isotype Control

IC002-100ul 100ul
EUR 146.4

Mouse IgM Isotype Control

E2790006 100ul
EUR 225
Description: Available in various conjugation types.

Mouse IgM Isotype Control

ICIGMF2-100 100 tests
EUR 396

Mouse IgM Isotype Control

ICIGMPU2-100 100 tests
EUR 396

Rat IgG2a Isotype Control

RIGG2AA-100 100 µg
EUR 374.5

Rat IgG2a Isotype Control

RIGG2AA-25 25 µg
EUR 217.25

Rat IgG2a Isotype Control

RIGG2AB-200 200 µg
EUR 549.22

Rat IgG2a Isotype Control

RIGG2AB-50 50 µg
EUR 269.66

Rat IgG2a Isotype Control

RIGG2AF-200 200 µg
EUR 374.5

Rat IgG2a Isotype Control

RIGG2AF-50 50 µg
EUR 199.78

Rat IgG2a Isotype Control

RIGG2APE-100 100 µg
EUR 339.55

Rat IgG2a Isotype Control

RIGG2APE-25 25 µg
EUR 199.78

Rat IgG2a Isotype Control

RIGG2APP-100 100 µg
EUR 688.99

Rat IgG2a Isotype Control

RIGG2APP-25 25 µg
EUR 322.08

Rat IgG2a Isotype Control

RIGG2APP5.5-100 100 µg
EUR 776.35

Rat IgG2a Isotype Control

RIGG2APP5.5-25 25 µg
EUR 339.55

Rat IgG2a Isotype Control

RIGG2APU-50 50 µg
EUR 217.25

Rat IgG2a Isotype Control

RIGG2APU-500 500 µg
EUR 479.33

Rat IgG2b Isotype Control

RIGG2BA-100 100 µg
EUR 391.97

Rat IgG2b Isotype Control

RIGG2BA-25 25 µg
EUR 199.78

Rat IgG2b Isotype Control

RIGG2BB-200 200 µg
EUR 549.22

Rat IgG2b Isotype Control

RIGG2BB-50 50 µg
EUR 269.66

Rat IgG2b Isotype Control

RIGG2BF-200 200 µg
EUR 566.69

Rat IgG2b Isotype Control

RIGG2BF-50 50 µg
EUR 182.3

Rat IgG2b Isotype Control

RIGG2BPE-100 100 µg
EUR 322.08

Rat IgG2b Isotype Control

RIGG2BPE-25 25 µg
EUR 182.3

Rat IgG2b Isotype Control

RIGG2BPP-100 100 µg
EUR 688.99

Rat IgG2b Isotype Control

RIGG2BPP-25 25 µg
EUR 322.08

Rat IgG2b Isotype Control

RIGG2BPP5.5-100 100 µg
EUR 619.1

Rat IgG2b Isotype Control

RIGG2BPP5.5-25 25 µg
EUR 339.55

Rat IgG2b Isotype Control

RIGG2BPU-50 50 µg
EUR 147.36

Rat IgG2b Isotype Control

RIGG2BPU-500 500 µg
EUR 444.38

Rat IgG2c Isotype Control

RIGG2CA-25 25 µg
EUR 304.61

Rat IgG2c Isotype Control

RIGG2CB-50 50 µg
EUR 269.66

Rat IgG2c Isotype Control

RIGG2CF-50 50 µg
EUR 304.61

Rat IgG2c Isotype Control

RIGG2CPE-25 25 µg
EUR 287.14

Rat IgG2c Isotype Control

RIGG2CPP5.5-25 25 µg
EUR 339.55

Rat IgG2c Isotype Control

RIGG2CPU-50 50 µg
EUR 217.25

Rat IgG2c Isotype Control

RIGG2CPU-500 500 µg
EUR 479.33

Mouse IgG1 Isotype Control

abx139001-01mg 0.1 mg
EUR 376.8

Mouse IgG1 Isotype Control

abx139002-01mg 0.1 mg
EUR 376.8

Mouse IgG1 Isotype Control

abx139008-01mg 0.1 mg
EUR 376.8

Mouse IgG3 Isotype Control

abx139010-01mg 0.1 mg
EUR 376.8

Mouse IgG1 Isotype Control

abx200564-100ug 100 ug
EUR 376.8

Mouse IgG3 Isotype Control

abx200587-100ug 100 ug
EUR 427.2

Mouse IgG1 Isotype Control

abx405007-01mg 0.1 mg
EUR 493.2

Mouse IgG1 Isotype Control

abx405009-05mg 0.5 mg
EUR 828

Mouse IgG1 Isotype Control

abx405012-1mg 1 mg
EUR 1296

Mouse IgG3 Isotype Control

abx405035-01mg 0.1 mg
EUR 493.2

Mouse IgG1 Isotype Control

abx405064-100tests 100 tests
EUR 493.2

Mouse IgG1 Isotype Control

abx405067-05mg 0.5 mg
EUR 994.8

Rabbit IgG Isotype Control

abx125003-100ul 100 ul
EUR 243.6

Rabbit IgG Isotype Control

IC001-100ul 100ul
EUR 146.4

Rabbit IgG isotype control

AC042 100μL
EUR 292.5
Description: None

Mouse IgG1 Isotype Control

E2790003 100ul
EUR 225
Description: Available in various conjugation types.

Mouse IgG1 Isotype Control

ICIGG1PU-01MG 100 tests
EUR 126.5

human IgG1 ( ()-isotype) control

E4A11C02 50ug
EUR 255
Description: Available in various conjugation types.

Mouse IgG2a Isotype Control

abx139004-01mg 0.1 mg
EUR 376.8

Mouse IgG2a Isotype Control

abx139005-01mg 0.1 mg
EUR 376.8

Mouse IgG2b Isotype Control

abx139006-01mg 0.1 mg
EUR 376.8

Mouse IgG2a Isotype Control

abx139009-01mg 0.1 mg
EUR 376.8

Mouse IgG2b Isotype Control

abx139011-01mg 0.1 mg
EUR 376.8

Mouse IgG2a Isotype Control

abx200572-100ug 100 ug
EUR 376.8

Mouse IgG2b Isotype Control

abx200580-100ug 100 ug
EUR 376.8

Rabbit Isotype Control (FITC)

abx200647-100test 100 test
EUR 393.6

Mouse IgG2a Isotype Control

abx405013-100tests 100 tests
EUR 493.2

Mouse IgG2a Isotype Control

abx405015-05mg 0.5 mg
EUR 828

Mouse IgG2a Isotype Control

abx405018-1mg 1 mg
EUR 1328.4

Mouse IgG2b Isotype Control

abx405056-100tests 100 tests
EUR 493.2

Mouse IgG2b Isotype Control

abx405061-1mg 1 mg
EUR 1296

Mouse IgG2a Isotype Control

abx405070-100tests 100 tests
EUR 493.2

Mouse IgG2a Isotype Control

abx405073-05mg 0.5 mg
EUR 994.8

Mouse IgG2a Isotype Control

10R-I117d 1 mg
EUR 663.6
Description: Purified Mouse IgG2a Isotype Control

Mouse IgG2a Isotype Control

E2790004 100ul
EUR 225
Description: Available in various conjugation types.

Mouse IgG2b Isotype Control

E2790005 100ul
EUR 225
Description: Available in various conjugation types.

IgG Isotype Control antibody

10R-6524 50 ug
EUR 159.6
Description: Armenian Hamster monoclonal IgG Isotype Control antibody

IgG Isotype Control antibody

10R-6525 50 ug
EUR 159.6
Description: Syrian Hamster monoclonal IgG Isotype Control antibody

PE rat IgG1, Isotype Control

E16FRCP001-025U 25 μg
EUR 303.33
Description: Available in various conjugation types.

PE rat IgG1, Isotype Control

E16FRCP001-100U 100 μg
EUR 715
Description: Available in various conjugation types.

PE Goat IgG Isotype Control

E16FGCP006-100 100 tests
EUR 368.33
Description: Available in various conjugation types.

Mouse IgM Isotype Control (PE)

abx139032-01mg 0.1 mg
EUR 510

Rat IgG1 Isotype Control (RPE)

abx405042-100tests 100 tests
EUR 427.2

Rat IgG2a Isotype Control PE

1P-168-C025 0.025 mg
EUR 146.4

Rat IgG2a Isotype Control PE

1P-168-C100 0.1 mg
EUR 244.8

Mouse IgM Isotype Control PE

1P-803-C025 0.025 mg
EUR 146.4

Mouse IgM Isotype Control PE

1P-803-C100 0.1 mg
EUR 244.8

Mouse IgM Isotype Control (PE)

E2790001 100ul
EUR 225
Description: Available in various conjugation types.

PE mouse IgM Isotype Control

E16FMCP004-050 50 tests
EUR 235.2
Description: Available in various conjugation types.

PE mouse IgM Isotype Control

E16FMCP004-100 100 Tests
EUR 336
Description: Available in various conjugation types.

APC rat IgG1, Isotype Control

E16FRCA001-025U 25 μg
EUR 325
Description: Available in various conjugation types.

APC rat IgG1, Isotype Control

E16FRCA001-100U 100 μg
EUR 736.67
Description: Available in various conjugation types.

Rat IgG2b Isotype Control PE

1P-169-C100 0.1mg
EUR 198

Mouse IgG1 Isotype Control (PE)

abx139025-01mg 0.1 mg
EUR 510

Mouse IgG1 Isotype Control (PE)

abx200566-50ug 50 ug
EUR 510

Mouse IgG3 Isotype Control (PE)

abx200589-50ug 50 ug
EUR 727.2

Rat IgG1 Isotype Control (FITC)

abx200645-200ug 200 ug
EUR 661.2

Rat IgG1 Isotype Control (FITC)

abx405021-100tests 100 tests
EUR 410.4

Rat IgG2a Isotype Control (RPE)

abx405026-100tests 100 tests
EUR 427.2

Rat IgG1 Isotype Control (FITC)

abx405040-01mg 0.1 mg
EUR 410.4

Rat IgG2a Isotype Control (APC)

abx405043-100tests 100 tests
EUR 510

Rat IgG2a Isotype Control (RPE)

abx405048-100tests 100 tests
EUR 427.2

Rat IgG2b Isotype Control (APC)

abx405049-100tests 100 tests
EUR 510

Rat IgG2b Isotype Control (RPE)

abx405055-100tests 100 tests
EUR 427.2

Mouse IgG1 Isotype Control PE

1P-632-C025 0.025 mg
EUR 146.4

Mouse IgG1 Isotype Control PE

1P-632-C100 0.1 mg
EUR 244.8

Mouse IgM Isotype Control (APC)

E2790224 100ul
EUR 225
Description: Available in various conjugation types.

Mouse IgG1 Isotype Control (PE)

E2790238 100ul
EUR 225
Description: Available in various conjugation types.

For occasion, Electronic Health Records are normally administered by governments. Electronic Medical Records are sometimes managed by well being care suppliers, whereas Personal Health Records are managed straight by sufferers. Recently, Blockchain-based well being report programs largely regulated by know-how have emerged as one other sort of repository. Repositories for storing well being knowledge differ from each other primarily based on price, stage of safety and high quality of efficiency. Not solely has the kind of repositories elevated lately, however the quantum of well being knowledge to be saved has elevated.

ChloroSSRdb: a repository of perfect and imperfect chloroplastic simple sequence repeats (cpSSRs) of green plants.

ChloroSSRdb: a repository of perfect and imperfect chloroplastic simple sequence repeats (cpSSRs) of green plants.

Simple sequence repeats (SSRs) are areas in DNA sequence that comprise repeating motifs of size 1-6 nucleotides. These repeats are ubiquitously current and are present in each coding and non-coding areas of genome.

A complete of 534 full chloroplast genome sequences (as on 18 September 2014) of Viridiplantae can be found at NCBI organelle genome useful resource.

It gives alternative to mine these genomes for the detection of SSRs and retailer them within the kind of a database. In an try and correctly handle and retrieve chloroplastic SSRs, we designed ChloroSSRdb which is a relational database developed utilizing SQL server 2008 and accessed by ASP.NET.

It gives data of all of the three varieties (perfect, imperfect and compound) of SSRs. At current, ChloroSSRdb comprises 124 430 mined SSRs, with majority mendacity in non-coding area.

Out of these, PCR primers have been designed for 118 249 SSRs. Tetranucleotide repeats (47 079) have been discovered to be probably the most frequent repeat sort, whereas hexanucleotide repeats (6414) being the least ample.

Additionally, in every species statistical analyses have been carried out to calculate relative frequency, correlation coefficient and chi-square statistics of perfect and imperfect SSRs. In accordance with the rising curiosity in SSR research, ChloroSSRdb will show to be a helpful useful resource in growing genetic markers, phylogenetic evaluation, genetic mapping, and many others. Moreover, it would function a prepared reference for mined SSRs in out there chloroplast genomes of green vegetation.

ChloroSSRdb: a repository of perfect and imperfect chloroplastic simple sequence repeats (cpSSRs) of green plants.
ChloroSSRdb: a repository of perfect and imperfect chloroplastic simple sequence repeats (cpSSRs) of green plants.

SpliceProt: a protein sequence repository of predicted human splice variants.

The mechanism of various splicing within the transcriptome might improve the proteome range in eukaryotes. In proteomics, a number of research goal to make use of protein sequence repositories to annotate MS experiments or to detect differentially expressed proteins.

However, the out there protein sequence repositories should not designed to totally detect protein isoforms derived from mRNA splice variants. To foster data for the sphere, right here we introduce SpliceProt, a new protein sequence repository of transcriptome experimental knowledge used to research for putative splice variants in human proteomes. Current model of SpliceProt comprises 159 719 non-redundant putative polypeptide sequences.

The evaluation of the potential of SpliceProt in detecting new protein isoforms ensuing from various splicing was carried out through the use of publicly out there proteomics knowledge. We detected 173 peptides hypothetically derived from splice variants, which 54 of them should not current in UniprotKB/TrEMBL sequence repository.

In comparability to different protein sequence repositories, SpliceProt comprises a higher quantity of distinctive peptides and is ready to detect extra splice variants. Therefore, SpliceProt gives a resolution for the annotation of proteomics experiments relating to splice isofoms.